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Minister of State’s Foreword
Implementing a policy such as the National Drugs Strategy over an extended period is a challenging task. It is 
important to keep focus and maintain momentum. To bring this about, I believe that it is important to build 
in a review mechanism that can take stock and assess the direction and continued relevance of the Strategy. 
As this report details, despite advances in many areas, gaps remain to be filled in the next three years. In this 
regard, while progress may not always have been as fast as we would have liked, the aims and objectives of the 
Strategy remain fundamentally sound. Where the Steering Group has found issues that need to be addressed 
or prioritised for the remaining period of the Strategy, they have made appropriate recommendations. In this 
regard, the mid-term review has not only allowed us time to reflect on and assess where we are but also to 
recommit to the Strategy for the next three years.
Since I have become Minister of State with responsibility for the National Drugs Strategy, I have met many 
people working in the drugs field in communities all over the country. They have urged the Government to stay 
committed to implementing this Strategy and not to settle for the progress that we all acknowledge has been 
made in recent years. I want to reassure all involved in this area that our commitment to tackling drugs misuse, 
particularly the drugs that do most harm and to the most vulnerable users and their families, remains as strong 
as ever. Indeed, the thorough examination of the Strategy that has been undertaken in this review, the wide-
ranging consultation process and the partnership approach adopted in the framing of this report, is I believe, 
further evidence of the Government’s ongoing commitment to addressing drug misuse in Ireland. I further 
believe that the recommendations set out in this report will serve to re-focus and re-energise the Strategy in the 
remaining period up to 2008.
Finally, I would like to thank all those involved in the process, those who met with the Steering Group, those 
who made submissions and came to the public fora and, particularly, the members of the Steering Group who 
have worked so hard in compiling this report. 
 
Noel Ahern T.D. 
Minister of State for the National Drugs Strategy
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Introduction
Like many countries throughout the world, 
problem drug use in Ireland continues to be a 
major challenge. While cannabis remains the most 
commonly used illegal drug in Ireland, in terms of 
harm to the individual and the community, heroin 
continues to have the greatest impact. The most 
recent estimates indicate that there are approx 
14,500 opiate users in Ireland, of which there are 
roughly 12,500 in Dublin.
Ireland’s seven year National Drugs Strategy was 
launched in May 2001 and is delivered through four 
inter-connected pillars dealing with:
■ supply reduction;
■ prevention (including education and awareness);
■ treatment (including rehabilitation and risk 
reduction); and
■ research.
2004 marked the half-way point of the Strategy 
and a mid-term review was initiated in June last 
year. The review was overseen by a Steering Group 
chaired by the Department of Community, Rural 
and Gaeltacht Affairs.
The overall aim of the review was to examine 
the progress being made in achieving the key 
strategic goals set out in the Strategy and to enable 
priorities for future action to be identified – and a 
re-focussing of the Strategy if necessary – for the 
remaining period up to 2008. The Steering Group 
was also asked to examine the relevance of the 
Strategy in tackling the current nature and extent of 
drug misuse in Ireland, including emerging trends, 
and to identify any gaps presenting and how they 
might be addressed.
From the outset, the Steering Group was cognisant 
of the fact that the Government has positioned the 
National Drugs Strategy within the context of wider 
social inclusion policy. The recommendations in 
this report are framed in this context and the focus 
of the Strategy will continue to be on illegal drugs 
that do most harm and on the most vulnerable drug 
misusers, families and communities.
The approach adopted by the Steering Group was 
influenced by a number of factors. In particular, 
the Group recognised that this is a mid-term 
review of the Strategy and, as such, represents a 
stock-take of progress at this half-way point, when 
the implementation of some of the actions is still 
ongoing.
In keeping with the terms of reference of the review, 
the report looks broadly at progress made to date 
under the Strategy’s 100 actions and identifies a 
number of areas that need to be prioritised in the 
remaining period up to 2008. In this context, the 
Steering Group found that many of the actions 
requiring multi-agency involvement are more 
challenging in terms of their implementation – than 
those where a single Department or agency has 
primary responsibility.
In looking at progress, the Steering Group drew 
on material contained in the recently published 
National Drugs Strategy Progress Report1 which 
outlines in greater detail progress on individual 
actions (although in some cases there have been 
further developments since that report was 
compiled). In addition, the Progress Report looks 
at the nature and extent of drug misuse in Ireland 
drawing on relevant research as well as looking at 
developments in relation to other drugs initiatives 
such as the Local Drugs Task Forces and the Young 
Peoples Facilities and Services Fund.
In their work, the Steering Group took account of  
the various issues raised during the consultation 
process as well as new emerging trends, such as  
the increased prevalence of heroin outside of the 
Eastern region and the increased prevalence of 
cocaine. The Group also drew on the work of the 
consultants (PA Consulting Group), on relevant 
research findings, and, importantly, on the group’s 
own experiences working in the drugs field.
In framing its recommendations, the Group 
concentrated on what it considered to be the most 
pertinent issues in terms of the future development 
and implementation of the Strategy. Where it was 
found that there are significant issues in relation 
to the delivery of existing actions, these are 
highlighted in the analysis under each pillar and 
it is recommended that their implementation be 
given renewed focus and priority for the remainder 
of the Strategy. In some cases, new actions 
– or amendments to existing actions – are being 
recommended both to deliver existing targets as 
well as to meet the changing nature of drug use.
Where appropriate, the report also proposes 
new ways of measuring progress through revised 
performance indicators, in line with the lessons 
emerging from the review and developments in 
research and data availability.
A number of the issues that arose during the review 
do not readily lend themselves to consideration 
under the existing pillar approach that shapes the 
Strategy. These include issues such as alcohol misuse 
and family support. These issues are examined in 
Chapter 7 – which looks at institutional structures 
– and a number of recommendations are made.
Finally, in its work the Steering Group noted that 
a distinctive feature and strength of the National 
Drugs Strategy to date has been the bringing 
1 National Drugs Strategy 2001-2008 Progress Report published by the Department of Community, Rural & Gaeltacht Affairs in  
March 2005.
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together of the key players – both statutory and 
community & voluntary – working in partnership to 
develop a range of responses to tackle drug misuse, 
building on evidence-based approaches. The Group 
recognises the ongoing value and importance of 
this way of working which will continue to be one 
of the cornerstones of Ireland’s Drugs Strategy into 
the future.
STRUCTURE OF THE REPORT
The Steering Group’s Report is structured as follows:
■ Chapter 1 – The Process – This chapter outlines 
the terms of reference for the review and the 
process through which it was conducted by the 
Steering Group.
■ Chapter 2 – Overview of the issues emerging 
from the consultation process – this chapter 
synopsises the main views put forward during 
the extensive consultation process which was 
carried out as part of the review.
■ Chapter 3 – Supply Reduction Pillar – this 
chapter outlines progress made to date across 
the actions under this pillar, identifies areas 
that need to be prioritised in the remaining 
period of the Strategy and makes a number of 
recommendations in this regard.
■ Chapter 4 – Prevention, Education & Awareness 
Pillar – this chapter outlines progress made 
to date across the actions under this pillar, 
identifies areas that need to be prioritised in the 
remaining period of the Strategy and makes a 
number of recommendations in this regard.
■ Chapter 5 – Treatment, Rehabilitation & Risk 
Reduction Pillar – this chapter outlines progress 
made to date across the actions under this pillar, 
identifies areas that need to be prioritised in the 
remaining period of the Strategy and makes a 
number of recommendations in this regard.
■ Chapter 6 – Research Pillar – this chapter 
outlines progress across the actions under 
the research pillar, identifies areas that need 
to be prioritised in the remaining period 
of the Strategy and makes a number of 
recommendations in this regard.
■ Chapter 7 – Institutional Structures of the 
National Drugs Strategy – this chapter looks 
at the institutional structures supporting the 
implementation of the Strategy and makes a 
number of recommendations in this regard.
■ Chapter 8 – Conclusions of the Steering Group 
– this chapter outlines the key conclusions of 
the Steering Group and looks at a number of 
other issues that arose during the course of the 
review.
In addition, attached to each pillar chapter is a 
table which gives an assessment of the state of 
play in relation to the actions in the Strategy. These 
assessments are a snapshot of progress, although 
it must be recognised that this is a dynamic 
situation and, in many cases, the best available 
information dates from 2004. As outlined above, 
further detail on all the actions is contained in the 
recently published National Drugs Strategy Progress 
Report. In order to present the actions in an easily 
accessible format, they are colour coded as follows:
Green – This refers to actions that have either been 
completed (e.g action 45) or relate to actions that 
are a continuing or ongoing task such as terms of 
reference or relate to continuing policy or mode of 
operation of a Department or Agency (e.g. action 
14). In other words, this does not refer to actions 
where work is ongoing to deliver actions not yet 
completed.
Yellow – This refers to actions where progress has 
been made and more work is ongoing to deliver the 
action by the relevant body concerned. Naturally, 
the progress made in this regard varies and a 
number are more advanced than others and are 
closer to completion.
Blue – This refers to actions where a very significant 
amount of work remains to deliver the action. It is 
important to stress that, in all cases, this does not 
mean that progress has not already been made 
but, rather, that a considerable amount remains to 
be done. This is often due to the size of the task 
concerned or because wider policy developments 
have impacted on the way in which actions will be 
implemented and on timescales. A number of these 
actions were highlighted during the review process 
and are addressed in the body of the chapter and 
through the recommendations.
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CHAPTER 1 
THE MID-TERM 
REVIEW PROCESS
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1 The Mid-term Review 
Process
1.1 In April 2004, Mr Noel Ahern, TD, Minister of 
State with responsibility for the National Drugs 
Strategy (NDS) established a Steering Group to 
oversee the mid-term review of the Strategy. The 
Steering Group – chaired by Ms Kathleen Stack 
of the Drugs Strategy Unit of the Department of 
Community, Rural & Gaeltacht Affairs – comprised 
representatives of a number of Departments, 
agencies and the community and voluntary 
sectors involved in implementing the Strategy. PA 
Consulting Group assisted the Steering Group in its 
work. Membership of the Steering Group is set out 
in Appendix 1.
1.2 The Terms of Reference of the Steering Group 
were as follows:
■ To examine the progress and the impact 
of the NDS across the four pillars of supply 
reduction, prevention, treatment and research 
in the context of the objectives set for it, 
the 100 actions assigned to be implemented 
by Departments and Agencies and the cost 
effectiveness of the various elements;
■ To examine the relevance of the objectives and 
actions in tackling the current nature and extent 
of drug misuse in Ireland, including emerging 
trends, and identify any gaps presenting and 
how they might be addressed;
■ To review the operational effectiveness of the 
structures of the NDS, including co-ordination 
mechanisms;
■ Develop performance indicators and baselines 
in order to measure the effectiveness of the 
NDS in the future;
■ In light of the foregoing, to consider how the 
Strategy, including the structures involved in its 
delivery, should be re-focussed or modified for the 
remaining period of the Strategy up to 2008; and
■ To make recommendations to the Cabinet 
Committee on Social Inclusion on the basis of 
the findings.
1.3 In order to ensure that the review reflected as 
broad and varied a perspective on the Strategy and 
its future direction as possible, the Steering Group 
undertook a wide-ranging and intensive programme 
of consultation. This programme included (i) 
written submissions from interested parties, (ii) 
regional public fora throughout the country, (iii) oral 
hearings with relevant bodies and interest groups 
and (iv) consultations with a number of young 
people from targeted areas.
1.4 Advertisements were placed in national, 
provincial and local newspapers in June 2004 
seeking written submissions from interested 
individuals and groups. The Steering Group, also 
wrote to a number of Government Departments, 
State Agencies, Local Authorities, Health Boards, 
County Development Boards, Community Groups, 
Voluntary Organisations etc. seeking their input 
into the consultation process. Arising from this, 
over 120 written submissions were received from a 
cross-section of statutory, voluntary and community 
organisations, as well as members of the public. A 
list of those who made submissions is attached at 
Appendix 2.
1.5 Public consultation fora were held in Galway, 
Limerick, Waterford, Carrick-on-Shannon and 
Dublin during October 2004. These locations were 
chosen to ensure a wide geographical spread and to 
facilitate as many people as possible to participate 
in the consultation process. The fora were attended 
by members of the public, TDs, City and County 
Councillors, representatives of statutory agencies, 
community and voluntary groups and Regional 
and Local Drugs Task Force members. Members of 
the Steering Group and PA Consulting Group also 
attended.
1.6 The format of the fora was identical irrespective 
of location. Minister of State Ahern chaired each 
forum and a wide-ranging and informative debate 
on the issue of drug misuse in Ireland, and the 
effectiveness of the National Drugs Strategy, took 
place at each of them. Central to each forum were 
workshops to discuss progress under the four pillars 
which underpin the Strategy – Supply Reduction, 
Prevention, Treatment and Research. Workshop 
participants were asked to give their views on the 
strengths and weaknesses of the current approach 
to the Strategy, to identify gaps they felt needed 
to be addressed and to consider new emerging 
trends. The deliberations of the workshops were 
fed back to the full forum and an open discussion 
held. Conclusions from the fora were considered 
by the Steering Group and have informed the 
recommendations of this review, as outlined in later 
chapters.
1.7 Twenty-five Government Departments, 
Agencies, Community Groups and Voluntary 
Organisations involved in implementing the Strategy 
made presentations to the Minister of State and 
the Steering Group on their views on progress to 
date and their perspectives on what should be 
the priorities going forward. The outcome of these 
presentations has also informed the work of the 
Steering Group. A list of the bodies who made 
presentations is set out in Appendix 3.
1.8 The Steering Group sought advice from the 
National Children’s Office on setting up a separate 
consultation process to capture the views of 
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young people in vulnerable communities. In all, 
five consultations were held with these young 
people ranging in ages from 12 to 20 years. These 
consultations were for the most part held in the 
same regional centres as the broader regional 
consultations (with the exception of Carrick-
on-Shannon which was replaced by Sligo). The 
outputs were synthesised and formed part of the 
deliberations of the Steering Group.
1.9 The Steering Group was assisted in its work by 
PA Consulting Group who reviewed the Strategy in 
terms of progress achieved, impact and emerging 
trends, gaps in service provision and provided 
their overall conclusions on the review process. 
They also reviewed key national and EU data 
to assess progress and impacts. Their work was 
supplemented, as necessary, by interviews with key 
players involved in the Strategy.
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CHAPTER 2 
OVERVIEW 
OF ISSUES 
ARISING FROM 
CONSULTATION 
PROCESS
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2 Overview of 
Issues arising from 
Consultation Process
2.1 As was the case with the consultation process 
leading to the development of the National 
Drugs Strategy 2001-2008, the extensive public 
consultation carried out by the Steering Group 
revealed a mature level of understanding of 
the nature of the current drug problem and the 
burden it places on individuals, their families and 
communities and society generally. All phases of 
the consultation attracted individuals and groups 
who were affected by the issue of drug misuse, or 
had a particular interest or responsibility in tackling 
the problem. This chapter is a synopsis of the 
views put forward during the consultation process 
without comment by the Steering Group on those 
views. Discussions held throughout the consultation 
process (including the public fora) were frank and 
wide-ranging and the main issues which emerged 
are listed below.
SUPPLY REDUCTION
2.2 There is a public perception that a greater 
range and volume of drugs are now more freely 
available within communities, despite increases in 
the number and volume of seizures by the Gardaí 
& Customs. Many contributors to the consultation 
phase saw heroin as a Dublin problem but others 
saw it as a growing problem in some other parts 
of the country. However, generally outside Dublin, 
the main profile of the drugs market is seen to be 
centred around cannabis, cocaine, ecstasy as well 
as prescribed and non-prescribed drugs. Cocaine 
is seen as an increasing problem. Its availability 
and the mobility with which supply networks can 
operate is also of concern. Also of rising concern is 
the illicit market for prescribed drugs, for example, 
benzodiazepines.
2.3 The role of community-oriented policing, and 
engagement with the community in curtailing the 
influence of drug-related organised crime, was 
raised throughout the consultations. Community 
groups, in particular, emphasised throughout the 
process that communication between communities 
and the Gardaí needs to improve to facilitate 
better exchange of information in order to more 
actively pursue action on tackling drug dealing. 
Many participants felt that offences with regard to 
possession were being pursued more readily by the 
Gardaí than supply offences. It was also felt that 
charges in relation to the possession of drugs for 
personal usage had the potential to alienate young 
people rather than act as a deterrent. There was 
a sense that the Gardaí were slow to respond to 
open dealing and to conduct surveillance of known 
dealers in communities. While there was recognition 
of the success that the Gardaí have had in relation 
to large seizures, there was frustration within local 
communities that enough is not being done. The lack 
of progress in developing the Community Policing 
Fora (CPF) model was also highlighted and is seen 
as a critical issue in many communities. There was 
a perceived need for more emphasis on resourcing 
CPFs in terms of support staff and funding.
2.4 In relation to Local Drugs Task Force (LDTF) 
areas, while the Garda Síochána can point to 
additional resources being assigned to these areas, 
the perception is that these additional resources 
have not been highly visible on the ground.
2.5 The need to strengthen the role of the 
Criminal Assets Bureau (CAB) to target medium-
scale dealers, who target the vulnerable within 
communities, was also raised. The view was 
expressed at a number of the sessions that CAB had 
lost its focus on seizing assets associated with drug 
dealers and the perception at local level is that it is 
now more concerned about tax evasion and other 
types of crime.
2.6 There was also frustration expressed that some 
local authorities are not actively implementing anti-
social behaviour policies to limit the activities of 
drug dealers in housing estates.
2.7 In relation to the judicial system, there was 
general support for the legislative framework but 
it was felt that judges should have more support 
and guidance in relation to sentencing. It was felt 
that the sentencing regime was inconsistent and 
guidelines should be drawn up to have a more 
consistent system and that there should be better 
communication on the rationale behind particular 
sentences. It was felt that alternative options 
to prison sentences should also be examined, 
particularly in the case of young offenders, and that 
there is a need for more arrest referral schemes, 
particularly in LDTF areas.
PREVENTION
2.8 The need to develop preventative measures to 
target those who are vulnerable, particularly those 
who are classified as “early school leavers” was 
raised. There was a perceived need to distinguish 
between initiatives in the formal school setting and 
non-school based setting. It was felt that the latter is 
of particular importance given the numbers who do 
not complete the school cycle and who represent a 
specific vulnerable group in the community. While 
there was support for initiatives like “Walk Tall” 
and “On My Own Two Feet” as part of the Social 
Personal Health Education (SPHE) programmes, 
the view was expressed that it is difficult to see the 
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impact on the ground. The involvement of parents 
and the wider community in delivering these 
programmes was suggested as a way of improving 
their effectiveness. Lack of consistency and 
continuity in programme delivery was also a key 
issue raised in the consultations and is emphasised 
in any research on this issue.
2.9 In relation to the requirement on schools to 
have substance use policies in place, concerns were 
expressed that there is a gap between what the 
Department of Education and Science requires and 
what is happening on the ground. It was felt that 
the guidelines on preparing policies are very good 
but the sense was that policies could be disciplinary, 
rather than supportive, and that some schools are 
not equipped to intervene appropriately.
2.10 The Young Peoples Facilities and Services Fund 
(YPFSF) is seen to be working well in providing 
facilities and services for young people at risk. It was 
also seen as useful in linking the various agencies 
involved in developing preventative programmes. 
However, the need to link the YPFSF more clearly 
to the Drugs Strategy was raised. It was felt that 
projects based in Dublin were in a better position 
to access funding under the programme. The 
lack of facilities in areas outside of the YPFSF 
jurisdiction was a major concern and it was felt 
that local authorities do not appear to have the 
capacity to get involved in the planning, funding or 
management of such facilities. In addition, facilities 
such as schools and community halls are often not 
available outside school hours and during school 
holidays. The client base is often discriminated 
against due to the social stigma associated with 
their drug misuse. Where facilities are available, 
there are management issues about how best 
to supervise them and what skills are needed to 
provide support.
2.11 The consultation process highlighted the 
perception that attitudes to certain drugs, such 
as cannabis, are changing with growing levels of 
“acceptance” across the country. There is also 
a perception that cocaine is now being viewed 
with more acceptance in some sections of the 
population. In addition, it was felt that the 
advertising of alcohol and tobacco (both of which 
are seen as gateway substances) contribute to 
the overall glamourisation of drugs and should 
be targeted. It was also felt that programmes are 
needed to educate young people about the dangers 
of so called “acceptable” drugs.
TREATMENT AND REHABILITATION
2.12 The need for treatment to focus on the person 
– and not the drug – was emphasised throughout 
the consultation process. It was felt that people had 
to “fit” into programmes, rather than services being 
delivered to meet individual needs. It was also felt 
that all addiction services should be needs-led, not 
just focussed on treatment. Views were expressed 
that new trends – polydrug use, cocaine, prescribed 
drugs, alcohol and drugs – require alternative 
treatment approaches. There is a perceived need for 
keyworkers to co-ordinate assessment and to work 
with family members. The timing of intervention 
is seen as critical and treatment options should 
be available when individuals are motivated. With 
regard to service-user charters, the service users 
themselves felt that they should have been more 
involved in the process of drafting the charters and 
that they should be consulted when they are being 
amended or revised.
2.13 Access to methadone treatment was seen 
as an important issue. It was pointed out that 
methadone treatment is not available in every local 
area which means that individuals have to travel 
distances to receive treatment with implications 
for employment prospects, cost of travel, child-
care etc. Attention was drawn to the waiting lists 
for methadone treatment that exist in some areas. 
Problems in sourcing GPs and pharmacists for 
methadone treatment were highlighted in some 
areas and it was felt that educational programmes 
should be made available to GPs and pharmacists 
to de-stigmatise addiction. While methadone 
maintenance has stabilised many drug misusers, 
there were concerns about the long-term effects 
of prolonged methadone use. There is a perceived 
need for more ancillary services to be made 
available to those on methadone.
2.14 The differences in availability and access to 
treatment and treatment options between different 
areas of the country were continually highlighted 
throughout the consultation process. Where a client 
lives is seen as critical to their ability to access 
treatment, with misusers in the Eastern area, and in 
some of our larger cities, faring better than those in 
the rest of the country. The focus on the medical/
clinical treatment model was not seen as relevant 
in many regions given the type of problem drug use 
in those areas (i.e. non prevalence of opiate use in 
some regions).
2.15 During the discussions, some key gaps in 
relation to treatment services were highlighted 
namely:
■ The need for residential/respite facilities and 
half-way houses;
■ Needle exchange programmes (to include 
mobile and pick-up services) need to be 
expanded;
■ Waiting lists to access services need to be 
shortened; and
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■ Access to services outside office hours needs to 
be expanded.
2.16 The health risks associated with hepatitis C 
and HIV and the lack of awareness of those risks 
were also raised – as was the linked issue of the 
need for more harm reduction measures generally.
2.17 In relation to prisons, views were expressed 
during the public consultation process that those 
who have a drug problem entering the prison system 
are in danger of continuing to misuse drugs due to 
the availability of such substances in some parts of 
the system. It was felt that the provision of training, 
counselling and education is essential to ensure 
that those being released have an increased chance 
of rehabilitation and pose a reduced risk of re-
offending. Concerns were expressed with regard to 
the potential for the spread of blood-borne illnesses 
in prison and the difficulties of employing the same 
range of harm reduction approaches in prison 
settings as are available in the community. The need 
for care planning and co-operation between the 
health and prison services in relation to prisoners on 
their committal and release, particularly in the case 
of early release, was highlighted.
2.18 Rehabilitation is seen as a critical issue and 
was a recurring theme during the consultations. 
A rehabilitation element to the overall Strategy is 
seen as essential in ensuring that drug users are not 
kept on methadone indefinitely. A clear definition 
of what rehabilitation is, and an identification of 
the agencies and groups that should be involved in 
providing such services, was called for throughout 
the consultation process. The emphasis throughout 
was that rehabilitation services need to be tailored 
to meet the client’s needs and to flow seamlessly 
from treatment, as part of the continuum of care.
2.19 Aftercare was seen as a key gap in terms of 
access to employment, sheltered and appropriate 
housing and relapse prevention and to break the 
cycle of drug dependence. The special Community 
Employment (CE) schemes for drug misusers 
and other FÁS schemes were mentioned in the 
consultation process as a very important element in 
the rehabilitation of drug misusers. However, there 
was a strong message throughout the consultation 
phase that there is a need for more rehabilitation 
services focussing on general life skills, as well as 
vocational opportunities.
RESEARCH
2.20 The research pillar did not feature as strongly 
as other pillars during the consultation process. 
However, the consultation process underlined the 
existence of information gaps within the system on 
topics such as trends in drug misuse, the operation 
of the criminal justice system, the operation 
of SPHE, funding of drug treatment services, 
treatments other than methadone etc. It was felt 
that while much more is now known about the drug 
problem in Ireland from a national perspective, 
more local and regionally based research is needed. 
The need for more clarity and information about 
the respective roles of the various agencies involved 
in drugs research – and their interaction with one 
another – was also raised.
FAMILY SUPPORT
2.21 The need to develop supports and guidance 
for parents, as well as children at risk, was 
highlighted. It was felt that parents and other 
family members are a neglected group who feel 
frustrated in seeking support for their children/
relatives. Parents and other family members can 
find it difficult to know where to turn when the 
domestic situation is chaotic as a result of a drug 
problem within the family. Further issues arise 
where the parents are drug misusers themselves 
and, in many cases, the grandparents or other 
relatives are faced with the task of raising children 
without adequate financial and other supports. 
The positive role families can play across all of the 
pillars of the Strategy was emphasised. The work 
and role of families is seen as being in some ways 
unacknowledged, while at the same time being an 
untapped resource. In discussing the role of families, 
it was felt that it must be noted that the family 
needs to be recognised as a support and resource, 
as well as having their support needs addressed.
ALCOHOL
2.22 The issue of alcohol was raised as a particular 
challenge – both as the preferred “drug of choice” 
for many and also because of its possible role as 
a “gateway” substance to other drugs. Linked to 
this is the question of having a combined drugs 
and alcohol strategy which was a recurring theme 
throughout the consultations, particularly in areas 
outside of Dublin.
STRUCTURES
2.23 The partnership approach to tackling drug 
misuse, which is seen as a unique feature of all 
of the levels of implementation of the National 
Drugs Strategy, was viewed very positively by 
participants in the consultation process. It was felt 
that the structures in place gave those working on 
the ground direct access to the decision-makers 
through the Cabinet Committee on Social Inclusion. 
However, a number of participants pointed out 
that the portfolio of the Minister of State with 
responsibility for the Drugs Strategy had been 
widened to encompass housing issues and this is 
seen as a signal of the declining importance of the 
drugs issue at national level.
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2.24 There was a perception that the roles of groups 
such as the Inter-Departmental Group on Drugs, 
the National Drugs Strategy Team, and the Drugs 
Strategy Unit of the Department of Community, 
Rural & Gaeltacht Affairs have become blurred over 
the years and that there is a need for more clarity 
around this issue. An increase in the number of 
community and voluntary representatives on the 
National Drugs Strategy Team was also called for. 
It was also felt that representatives of statutory 
agencies sitting at national and local fora should 
be well informed of their roles and have a clear 
understanding of what they should be adding to the 
process.
2.25 The issue of funding for drugs services was 
also raised throughout the process. It was felt that 
funding should be allocated on a multi-annual basis 
with arrangements made for staff pay increases so 
that they do not negatively impact on programme 
costs.
2.26 There was a sense that national agencies are 
not sufficiently linked up in terms of planning. There 
were strong arguments put by some participants 
that key implementing agencies should be 
“challenging themselves” more in terms of what 
they’re actually doing to implement the Strategy.
2.27 There was a sense of frustration in relation 
to the pace of development of the Regional Drugs 
Task Forces (RDTFs). The RDTFs are at different 
stages in mapping services, identifying priorities 
and developing plans. The need for the RDTFs 
to have full- time co-ordinators was repeatedly 
raised. Varying views were expressed about the 
independence of the co-ordinators with some 
participants strongly of the view that the co-
ordinators should be employees of the Health 
Services, with others strongly of the view that 
they should not. Community groups in some 
regions reported finding it difficult to engage with 
the RDTFs and there were questions about the 
commitment of statutory agencies in others.
2.28 Equally there was a sense of frustration about 
the resourcing of the LDTFs and what was seen 
as the slowness in the implementation of the 
recommendations of the Burtenshaw2 report in 
relation to additional staffing.
2.29 It was felt that the Strategy has worked well 
in terms of promoting inter-agency co-operation 
but is not reaching its full potential due to a lack of, 
or delay in, the implementation of some of its key 
actions. Interaction between services on the ground 
is perceived as working better but it still falls short 
of a streamlined, timely continuum of care. People 
are still seen to be slipping through the net. Where 
strong community-based projects are in place, it 
is felt that brokering and mediation for individuals 
appears to be less of a problem.
2  Review of the Local Drugs Task Forces, Rita Burtenshaw, MSc, July 2002. The National Drugs Strategy Team used this Report as the basis 
of a detailed review of LDTFs completed in December 2002.
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CHAPTER 3 
SUPPLY 
REDUCTION
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3 Supply Reduction
3.1 Of the 100 actions in the NDS, 21 are directed 
towards the supply reduction pillar (see pages 22-23 
for details). The Steering Group reviewed progress 
in relation to the various actions and found that 
many of them have advanced considerably since 
2001. In the case of 11 of the actions, they are 
either completed or are ongoing tasks over the 
lifetime of the Strategy (shown in green). In the 
case of a further 9 actions, while some progress has 
been made, further work is necessary or underway 
in order to complete the implementation of the 
actions (shown in yellow). The final action requires 
much more progress (shown in blue). The principal 
agencies involved in implementing actions under 
the supply reduction pillar are the Department of 
Justice, Equality & Law Reform, together with the 
Garda Síochána; the Revenue Commissioners, in 
particular Customs and Excise Service; the Courts 
Service; the Prison Service; the Probation and 
Welfare Service; the Department of Environment, 
Heritage & Local Government together with the 
Local Authorities; the LDTFs and the community 
and voluntary sectors.
3.2 A robust legislative framework (action 6) 
is in place and is continually reviewed to ensure 
that it can be adapted to meet emerging trends. 
The principal piece of legislation underpinning the 
prevention of the misuse of dangerous or otherwise 
harmful drugs is the Misuse of Drugs Act 1977. 
Other legislation currently in place includes:
■ Customs Consolidation Act 1876;
■ Customs and Excise (Miscellaneous Provisions) 
Act 1988;
■ The Criminal Justice Act 1994;
■ The Criminal Justice (Drug Trafficking) Act 1996;
■ The Criminal Assets Bureau Act 1996;
■ The Proceeds of Crime Acts 1996 to 2005;
■ The Licensing (Combating Drug Abuse) Act 
1997; and
■ The Criminal Justice Act 1999.
All of these legislative instruments are used on an 
ongoing basis by the Garda Síochána to combat 
national and international drug trafficking.
3.3 As part of its ongoing review of legislation, 
the Minister of Justice, Equality & Law Reform has 
tabled two new significant draft pieces of legislation 
– the Criminal Justice Bill 2004 and the Garda 
Síochána Bill 2004. A proposed amendment to the 
Criminal Justice Bill will, among other things, make 
it an offence to participate in or contribute to the 
activities of a criminal organisation. Included in 
the draft provisions of the Garda Síochána Bill are 
mechanisms for enhanced co-operation between 
the Gardaí and Local Authorities through the 
establishment of Joint Policing Committees (JPCs) 
to address local policing and other issues which 
come within the responsibility of Local Authorities. 
This includes the question of drug supply matters 
in local areas. The Steering Group emphasises, 
however, that having a robust legislative framework 
is not sufficient in itself to guarantee success – how 
it is implemented is critical. The Steering Group 
notes that local community and voluntary sector 
involvement is a key issue in this regard and that 
this is reflected in the provisions of the Garda 
Síochána Bill through local involvement at both the 
levels of the JPC and local community fora. The 
Group also notes that the Bill specifically provides 
that the JPC’s function is to serve as a forum for 
consultations, discussions and recommendations on 
matters affecting the policing of the local authority’s 
administrative area, and in particular, to keep under 
review the levels and patterns of crime, disorder 
and anti-social behaviour in that area (including 
the patterns and levels of misuse of drugs). Whilst 
policing issues may change in a community, the 
Steering Group feels that the JPCs should give 
priority to drug problems and related crime.
3.4 The Steering Group is aware of the calls from 
around the country to establish Community 
Policing Fora (action 11) outside of the areas in 
which they have been piloted. The principle of and 
need for effective mechanisms of engaging with 
communities is agreed both by the Garda Síochána 
and local communities. As outlined above, the 
Department of Justice, Equality & Law Reform is 
currently developing a legal framework through the 
Garda Síochána Bill to facilitate the development 
of formal and inclusive partnership arrangements 
on policing issues between the Gardaí and local 
communities. Models of community participation 
in policing have already been developed, however, 
through the CPFs. Progress in extending CPFs 
beyond the current areas is slow and emerged as an 
important concern during the consultation process, 
particularly for LDTFs and other areas experiencing 
problems of drug misuse. While there are many 
understandings of CPFs, the model as it operates 
in the Store Street Garda District3 (north inner city 
area of Dublin) is generally seen as the preferred 
model of co-operation. However, this type of CPF is 
resource intensive – in terms of finance, personnel 
and other resources. The Steering Group feels that 
the challenge now is to urgently explore how CPF 
arrangements can be extended to other areas of the 
country, bearing in mind the developments in the 
Garda Síochána Bill and resource implications. The 
Steering Group is concerned that the new legislation 
should not delay the roll-out of CPF arrangements 
and believes that action 11 should be re-prioritised.
3  This model involves the appointment of a full time co-ordinator who is not a member of the Gardaí but rather a representative of the 
community and the assignment of a Garda Officer on a full-time basis to work with the Forum.
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3.5 The Steering Group found that there were 
strong perceptions among the public around the 
operation of the criminal justice system and 
enforcement practice. These perceptions include 
low use of mandatory sentencing provisions, uneven 
enforcement and sentencing across geographic 
areas and a disproportionate focus on possession 
rather than supply of drugs4. These perceptions 
could potentially dilute public confidence in the 
deterrent value of the criminal justice system. In 
the circumstances, this will require the further 
development of robust information frameworks 
on the operation of the criminal justice system 
and wide dissemination of statistical information. 
Developments such as PULSE (Police Using 
Leading Systems Effectively) and the District Court 
Criminal Case Tracking System (CCTS) will lead 
to improvements in this area. The Steering Group 
notes that there have been significant developments 
in Information Technology in various areas of the 
criminal justice system which will facilitate progress 
in the establishment of a framework to monitor 
arrests, prosecutions and sentencing (action 4). 
However, there are still data gaps, particularly at 
inter-agency level, and the Steering Group believes 
there is a need now to focus on greater connectivity 
between systems and data. An internal working 
group in the Department of Justice, Equality & 
Law Reform is currently developing a framework 
as required by action 4 and the Steering Group 
considers that it should make recommendations 
as to how data should be disseminated once the 
framework is up and running with a view to making 
the data as widely available as possible.
3.6 The NDS includes actions on two specific 
aspects of the operation of the criminal justice 
system – monitoring the efficacy of the existing 
arrest referral schemes and their expansion, as 
appropriate (action 13), and the extension of the 
Drug Court model (action 20) to other LDTF areas, 
if it is positively evaluated. The Steering Group is 
aware that pilot arrest referral procedures have 
been put in place in Cork, Dún Laoghaire and 
Ballymun. In addition, a further pilot arrest referral 
scheme for juvenile offenders is in operation in 
the North Inner City LDTF area in Dublin. This 
has coincided with a recently completed research 
study of arrest referral schemes commissioned by 
the Task Force and funded by the Department of 
Justice, Equality & Law Reform. With regards to the 
pilot Drug Court, the Steering Group notes that 
following an evaluation of the model, it has been 
extended to the entire Dublin 7 area. This initial 
evaluation concluded that the original catchment 
area of the Court was too small to allow for a 
conclusive evaluation and so recommended that 
its area be extended. A further evaluation of the 
extended Drug Court will be carried out after which 
an informed decision can be taken in relation to 
its further expansion. The Steering Group is of the 
opinion that, subject to positive evaluations, both 
of these actions should be progressed past pilot 
stage, as a matter of urgency, and a decision made 
to extend the models to other areas or to put other 
approaches in place.
3.7 The Steering Group believes that the mid-
term review has revealed a need to engage with 
the Judicial Studies Institute on drug-related 
issues. The Group is conscious that the judiciary 
is completely autonomous and independent and 
must remain so but it believes that the provision 
of guidance or training for judges on drug-related 
issues should be explored with the Institute. The 
Steering Group is aware that the Institute has 
included the topic of drug misuse in conferences, 
seminars and publications but feels that there is 
scope for further co-operation going forward.
3.8 The Steering Group notes the work currently 
underway to advance action 19 which calls for 
early intervention to combat drug misuse among 
young people coming to Garda attention. A 
committee to advance this issue, which is chaired 
by the Department of Health & Children, has met 
on six occasions since June 2004. To date, the 
committee has consulted with service providers and 
gathered information and statistics from the Garda 
Síochána in order to identify the number, nature 
and contributory factors of incidences coming 
to Garda attention. The report of the Under 18s 
Working Group5 is also of considerable relevance 
to the work of this committee. The Steering 
Group understands that the committee will draw 
up recommendations for an appropriate referral 
framework for these young people and believes that 
these recommendations should be implemented as 
a matter of priority.
3.9 Three of the actions included in the NDS 
are aimed at strengthening dedicated drugs law 
enforcement arrangements through increasing 
resources in the LDTF areas (action 7), 
establishing a co-ordinating framework for 
drugs policy in each Garda District (action 8), and 
making additional resources available to drug 
units (action 10). The Gardaí have established 
Divisional Drug Units in virtually all divisions. In 
addition, a framework document on Divisional 
Drug Policing Plans has been prepared and liaison 
with communities on drug related matters will 
be an important part of the process. The Garda 
Síochána state that 134 additional Gardaí have been 
allocated to LDTF areas between January 2001 
and July 2004. However, there is a perception that 
these additional resources have not impacted on 
the ground in relation to the drugs issue and that 
increased resources are needed. The Steering Group 
4  The Garda Síochána point out that in all jurisdictions with equivalent legislation, there are naturally more charges for possession than 
supply.
5  The Under 18s Working Group was established in October 2001 to develop a protocol for the treatment of persons under 18 years of age 
presenting with serious drug problems. The Group was chaired by the Department of Health and Children and comprised a broad range 
of statutory and non-statutory service providers and community representatives. The Group’s Report will be published in mid 2005.
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notes that the Government has decided to increase 
overall Garda numbers from 12,000 to 14,000. In 
this regard, the Minister for Justice, Equality & Law 
Reform has stated that these additional resources 
will be targeted at the areas of greatest need, as is 
envisaged in the Programme for Government. Areas 
with a significant drug problem are a particular 
priority identified in the Programme. In keeping 
with this, the Steering Group believes that LDTF 
areas and other areas where a significant drug 
problem exists should be prioritised when allocating 
these additional resources.
3.10 A key strand of the NDS is to disrupt the 
activities of drug dealers and the Steering Group 
notes the many successes of the Garda Síochána 
and Customs and Excise over the period of the 
Strategy to date. However, the Group believes that 
the operations of middle-ranking suppliers and 
dealers need to be targeted further. The Steering 
Group is aware that the issue of strengthening 
mandatory sentencing provisions is being examined 
in the Department of Justice, Equality & Law 
Reform. However, the Group believes that the 
focus of such initiatives should be on those who 
profit from the supply of drugs and that, within the 
system, cognisance should be taken of those who 
act as ‘mules’ for other reasons such as funding 
their own habits or poor economic circumstances. 
The Steering Group suggests that this should be 
one of the issues to be addressed by the framework 
of co-operation with the Judicial Studies Institute 
proposed in the recommendations below.
3.11 The Steering Group believes that in 
conjunction with treatment, curbing the supply of 
illicit substances in prisons should be a goal of the 
Strategy. The Prison Service has taken a number of 
initiatives to achieve this over recent years such as 
netting over yards, new ‘pre-agreed visitor’ visiting 
arrangements and enhanced CCTV. The Group 
recommends that these efforts be continued.
3.12 The Steering Group notes the progress 
achieved under actions 14 to 18 by the Customs 
and Excise Service (C&E) and the Garda Síochána. 
The Memorandum of Understanding and Working 
Protocol between the Gardaí and C&E provides 
the framework for this co-operation. C&E, in turn, 
has over 40 Memoranda of Understanding with 
companies in the international travel and trade 
business sectors. The Gardaí and C&E also operate 
confidential drug watch programmes. C&E now 
has nine drug detector dog teams deployed at the 
main ports and airports and are putting in place a 
mobile container x-ray scanner, which will be used 
for detecting all contraband, including illicit drugs 
in commercial containerised traffic. In addition to 
improved liaison at national level, both the Gardaí 
and the C&E are actively participating in EU and 
other international fora.
3.13 The Steering Group notes the success of the 
Criminal Assets Bureau (CAB) in targeting the 
assets of drug dealers since its establishment in 
1996. The Group believes, however, that the Bureau, 
in pursuance of action 9 of the Strategy, should 
ensure that the assets of middle-ranking criminals 
are targeted on an ongoing basis. The Group 
acknowledges that this will require international 
co-operation to prevent drug traffickers from 
successfully moving assets abroad. The Group is 
also of the opinion that consideration should be 
given to using the monies made from drug-related 
crimes which are seized by CAB to fund drugs 
projects in the affected communities. The Steering 
Group is aware of the legislative and administrative 
difficulties which may arise in this regard but 
consider that the issue should be explored further 
as it would represent an important symbolic gesture 
to those communities most affected.
3.14 Due to the illegal nature of drug use, it is quite 
common for drug users to come to the attention 
of the Gardaí. Over the course of their drug-taking 
many drug users will receive criminal convictions 
and, subsequently, a criminal record. While being 
arrested can often precipitate drug users engaging 
in drug treatment, at the post-treatment level, a 
criminal conviction can prove a serious impediment 
to rehabilitation. A criminal conviction can pose 
a significant drawback in terms of employment, 
training and travel and makes successful re-
integration into mainstream society more difficult. 
The Steering Group is of the view that, as an aid 
to rehabilitation, consideration should be given to 
the development of Rehabilitation of Offenders 
legislation, similar to that which operates in other 
countries. This would allow for certain categories of 
criminal convictions to effectively become “spent” 
after a specified period of time. In this context, 
the Group has noted the references to this issue in 
the National Economic and Social Forum’s Report 
on the Re-integration of Prisoners (Forum Report 
No. 22) which was published in 2002. The Group 
recognises the complexities involved in this matter, 
not least the administrative and legal issues that it 
raises, which should not be underestimated.
3.15 The Steering Group believes that data 
collection and the provision of timely information 
will support the ongoing and future review and 
evaluation of the actions under this pillar. The 
Steering Group notes that the National Advisory 
Committee on Drugs (NACD)6 has prioritised drugs 
and crime in its new work programme which will 
further contribute to evidence based policy-making.
KEY ISSUES EMERGING
3.16 As outlined at the beginning of this chapter, 
progress has been made across the 21 actions in 
6  The National Advisory Committee on Drugs (NACD) was established in 2000 and advises the Government in relation to the prevalence, 
prevention, treatment and consequences of problem drug use in Ireland based on its analysis of research and information available 
to it. In 2004, the Government extended its mandate to 2008 and its new work plan will include research on drugs and crime and 
rehabilitation.
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the supply pillar. However, the Steering Group 
has identified three key issues which will need 
to be addressed over the remaining lifetime of 
the Strategy up to 2008. The Group believes that 
this can be done in the case of two of the issues 
through replacing or amending existing actions in 
the Strategy and in the case of the remaining issue 
through the development of a new action:
1.  ISSUE: Garda resources in LDTF areas – there 
is a perception that the additional resources 
allocated to LDTF areas have not impacted 
on the ground in relation to the drugs issue. 
LDTF areas and areas where a significant 
drug problem exists should be prioritised 
when decisions are being made regarding the 
deployment of the additional Gardaí that are to 
be recruited.
 Recommendation of Steering Group:
■ The level of Garda resources in LDTF areas 
should be increased and the additional 
resources should be assigned to community 
policing and the prevention of drug dealing 
(Action 7 replaced).
 Department/Agency responsible: An Garda 
Síochána
2.  ISSUE: Expansion of Community Policing 
Fora – Community Policing Fora are being 
piloted in a number of areas but progress in 
implementing them beyond the current areas is 
slow and is a particular concern, particularly in 
LDTF areas.
 Recommendation of Steering Group:
■ Taking into account the provisions of the 
Garda Síochána Bill 2004, Community 
Policing Fora (CPF) should be extended 
to all LDTF areas and to other areas 
experiencing problems of drug misuse 
(Action 11 replaced).
 Department/Agency responsible: An Garda 
Síochána
3.  ISSUE: Specialist training for judiciary on 
drug related issues – while recognising that 
the judiciary is completely autonomous and 
independent, it is believed that the provision of 
guidance or training for judges on drug-related 
issues should be explored with the Judicial 
Studies Institute.
 Recommendation of Steering Group:
■ A framework of co-operation with the 
Judicial Studies Institute on the provision 
of specialist training on drug-related issues 
to members of the Judiciary should be 
developed by January 2007 (New Action).
 Department/Agency responsible: Courts 
Service
KEY PERFORMANCE INDICATORS
3.17 As outlined in the introduction, the Steering 
Group has also examined the question of key 
performance indicators (KPIs) in relation to the 
various pillars. These indicators replace the existing 
KPIs and concentrate on available data and, where 
not specified, refer to the period up to the end of 
2008 (i.e. the end of the NDS).
In the case of the supply reduction pillar, the 
Steering Group proposes the following KPIs:
■ Volume of drugs seized increased by 50% based 
on 2000 figures;
■ Number of seizures increased by 20% based on 
2004 figures; and
■ Number of supply detections increased by 20% 
by end 2008 based on 2004 figures.
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PROGRESS ON ACTIONS OF THE SUPPLY REDUCTION PILLAR
No. Agency Action Progress
4 D/JELR To oversee the establishment of a framework to monitor 
numbers of successful prosecutions, arrests and the nature 
of sentences passed.
Progress made/more 
work underway
5 D/JELR To establish, in consultation with the Gardai and the 
community sector, best practice guidelines and approaches 
for community involvement in supply control activities with 
law enforcement agencies.
Progress made/more 
work underway
6 D/JELR To review the ongoing effectiveness of crime legislation, in 
tackling drug-related activity.
Completed or 
Ongoing Task
7 Garda 
Síochána
To increase the level of Garda resources in LDTF areas 
by end 2001 and build on lessons emanating from the 
Community Policing Forum (CPF) model.
Progress made/more 
work underway
8 Garda 
Síochána
To establish a co-ordinating framework for drugs policy 
in each Garda District, to liaise with the community on 
drug-related matters and act as a source of information for 
parents and members of the public. Each Garda District and 
Sub-District be required to produce a Drug Policing Plan to 
include multi-agency participation in targeting drug dealers.
Progress made/more 
work underway
9 Garda 
Síochána
To target the assets of middle-ranking criminals involved in 
drug dealing. 
Progress made/more 
work underway
10 Garda 
Síochána
To continue to target dealers at local level by making 
additional resources available to existing drugs units and for 
the establishment of similar units in areas where they do 
not currently exist.
Progress made/more 
work underway
11 Garda 
Síochána
To extend the Community Policing Fora (CPF) initiative to 
all LDTF areas, if the evaluation of the pilot proves positive. 
The proposed RDTFs should be consulted in assessing 
whether CPFs should be in regional areas of particular 
need. Where CPFs do not exist, CPF methods should be 
adopted for best practice for mainstream policing policy.
Considerably more 
progress required
12 Garda 
Síochána
To ensure that operations similar to Dóchas, Nightcap and 
Cleanstreet are implemented in urban centres throughout 
Ireland, where drug dealing is ongoing.
Completed or 
Ongoing Task
13 Garda 
Síochána
To monitor the efficacy of the existing arrest referral 
schemes and expand them, as appropriate.
Progress made/more 
work underway
14 Garda 
Síochána 
Customs & 
Excise
To continue to work more closely together in accordance 
with the principles of their Memorandum of Understanding. 
They should also co-operate and collaborate fully with 
law enforcement and intelligence agencies in Europe and 
internationally in reducing the amount of drugs coming into 
Ireland.
Completed or 
Ongoing Task
15 Garda 
Síochána 
Customs & 
Excise
To strengthen and consolidate existing coastal watch and 
other ports of entry measures designed to restrict the 
importation of illicit drugs by end 2002.
Completed or 
Ongoing Task
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No. Agency Action Progress
16 Garda 
Síochána 
Customs & 
Excise
To develop benchmarks against which seizures of heroin 
and other drugs can be evaluated under the EU Action Plan 
in order to establish progress on a yearly basis.
Completed or 
Ongoing Task
17 Garda 
Síochána 
Customs & 
Excise
To ensure greater integration of Customs and Excise within 
a European context, an Officer of the Customs and Excise 
Division should be appointed to the Europol National Unit.
Completed or 
Ongoing Task
18 Garda 
Síochána 
Customs & 
Excise 
To have available to the enforcement agencies detection 
dogs and other resources to restrict the importation of illicit 
drugs.
Completed or 
Ongoing Task
19 Garda 
Síochána 
and Health 
Boards
Incidences of early use of alcohol or drugs by young 
people coming to Garda attention to be followed up by the 
Community Police and/or the health and social services, in 
order that problem drug misuse may be diagnosed/halted 
early on through appropriate early intervention.
Progress made/more 
work underway
20 Courts 
Services
To have in all LDTF areas an early intervention system, 
based on the Drug Court model, if the evaluation in the 
North Inner City of Dublin is positive. This should be 
accompanied by appropriate familiarisation for the judiciary 
on the role of the Drug Court.
Progress made/more 
work underway
25 D/EHLG To commission an external evaluation of the impact of 
enforcement activity under the Housing Acts (evictions, 
excluding orders).
Completed or 
Ongoing Task
27 Gardaí, HBs, 
VFI, LVA 
and IHF
Representative bodies, including the Vintners Federation 
of Ireland (VFI), the Licensed Vintner’s Association (LVA) 
and the Irish Hotel Federation (IHF) to prepare guidelines, 
in association with the Garda Authorities and the Health 
Boards, for publicans and night-club owners, regarding 
drug dealing on, or in the vicinity of their premises. These 
guidelines should set out clearly the actions which the 
owner of the premises should take in response to drug 
dealing e.g. co-operation with the Gardaí etc.
Completed or 
Ongoing Task
28 Gardaí, HBs, 
VFI, LVA 
and IHF
Gardaí to object to the renewal of licences for publicans 
and night-club owners where there has been a history of 
drug dealing on the premises.
Completed or 
Ongoing Task
70 LAs & HBs To consider how the design of housing estates can 
contribute to the prevention of drug dealing in the context 
of ongoing reviews of the Social Housing Design Guidelines 
for Local Authority Estates. In this regard, the lessons 
learned from the Integrated Services Process (ISP) may  
be relevant.
Completed or 
Ongoing Task
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CHAPTER 4 
PREVENTION, 
EDUCATION & 
AWARENESS PILLAR
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4 Prevention, Education 
& Awareness Pillar
OVERVIEW OF PROGRESS
4.1 The NDS includes 16 actions (see pages 30-31 
for details) aimed at prevention, encompassing 
education and awareness, the essential aim of 
which is to reduce the demand for drugs. In the 
case of 11 of the actions, they are either completed 
or are ongoing tasks over the lifetime of the Strategy 
(shown in green). In the case of the remaining 
5 actions, while some progress has been made, 
further work is necessary or underway in order 
to complete the implementation of the actions 
(shown in yellow).7 The principal agencies involved 
in delivering these actions are the Departments 
of Education & Science and Health & Children; 
their associated agencies including the National 
Educational Welfare Board; Vocational Education 
Committees; the Health Service Executive (HSE); 
the LDTFs and the voluntary and community 
sectors.
4.2 The Steering Group reviewed progress in 
relation to the various actions and found that many 
of them have advanced considerably since 2001. 
In general, the Steering Group notes that there 
are now a range of school-based programmes and 
schemes in place aimed at tackling disadvantage, 
developing personal skills and making students 
more aware of issues around drugs. In addition, 
guidelines have been developed to facilitate all 
schools in drawing up substance use policies and a 
National Drugs Awareness Campaign highlighting 
issues around drug misuse is in place. A summary 
of progress across the various actions is outlined in 
this chapter. Issues highlighted during the course 
of the review which will need to be addressed 
in the remaining period of the Strategy are also 
highlighted.
4.3 Half of the 16 actions (actions 31-36 and 42-
43) relate to school-based prevention programmes 
which can broadly be categorised into (i) 
programmes to tackle educational disadvantage 
and (ii) dedicated programmes aimed at substance 
misuse.
4.4 A key priority in the Strategy has been to target 
schools in LDTF areas and other disadvantaged 
areas and to make additional supports available 
to these schools. The principal strands in the 
Department of Education & Science’s approach 
to educational disadvantage include the National 
Educational Welfare Board (NEWB), the School 
Completion Programme (SCP) and the Home 
School Community Liaison Scheme (HSCL). In the 
context of the NDS, the Steering Group notes that:
■ Action 30 called for the prioritisation of LDTF 
areas in the establishment of the NEWB, 
which was launched in December 2003. While 
there are now Educational Welfare Officers 
assigned to all LDTF areas, the Steering Group 
notes that the Board is not operating at its 
full complement. Notwithstanding the current 
difficulties in relation to employment ceilings, 
the Steering Group believes that there is a need 
to continue to expand the work of the Board to 
areas with high levels of drug misuse.
■ The SCP (relevant to action 36) has been in 
operation since 2002 and currently operates 
in 82 clusters nationwide, encompassing over 
400 schools. Similar to the NEWB, the Steering 
Group considers that there is a need to continue 
to expand the Programme to target areas with 
high levels of drug misuse and to evaluate its 
ongoing impact on the ground.
■ The HSCL Scheme (relevant to action 34) 
focuses on primary and post-primary schools 
that have been designated as disadvantaged. 
Through its network of co-ordinators in some 
500 schools, the HSCL now also includes 
advice to parents on substance misuse. While 
recognising the valuable work being done 
through the Scheme, the Steering Group 
considers that it could be further strengthened 
through the provision of additional resources. 
In particular, the Group considers that there 
is a need to expand the engagement of Home 
School Community Liaison with families, 
particularly those dealing with drug misuse.
4.5 With regard to dedicated programmes aimed 
at tackling substance misuse, the Steering 
Group notes that the Social, Personal and Health 
Education (SPHE) Programme (actions 31 and 
33) is a curriculum subject at both primary and 
post-primary level, up to Junior Certificate. At 
both levels, there are dedicated modules which 
focus on the “prevention of substance misuse” 
including alcohol. However, the review highlighted 
a number of issues in the delivery of SPHE around 
the country and, by extension, those modules 
dealing specifically with substance misuse. It was 
found that the practice of delivering SPHE can vary 
between schools suggesting that there may be 
capacity issues regarding implementation at local 
level. The fact that SPHE is not an exam subject was 
also highlighted as a factor in the perceived low 
prioritisation of this subject on school timetables. 
The Steering Group believes that consistency in 
the delivery of these programmes is critical to their 
successful implementation. In this context, the 
Group considers that ongoing training and support 
in prevention education should be made available 
for teachers and, furthermore, that it should be part 
of the curriculum for student teachers.
7  Action 34 has always been broken into two parts for assessment and has a dual colour coding. In terms of overall assessment it is 
deemed to not yet be completely in place.
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4.6 “Walk Tall” is a Substance Misuse Prevention 
Programme which is taught as part of SPHE at 
primary level (actions 32 and 34). The Walk Tall 
Support Service currently provides a range of 
supports to primary schools in LDTF areas to 
implement the Walk Tall Programme as part of the 
SPHE curriculum and to develop substance use 
policies. One of the challenges of the Walk Tall 
Programme is to provide continuing development 
for teachers on the programme. In addition, the 
Steering Group considers that there is a need 
to extend the comprehensive range of supports 
currently available to primary schools in LDTF areas 
through the Walk Tall Support Service to other areas 
of disadvantage.
4.7 The NDS (actions 34 and 35) also recommends 
exploring ways of involving parents and families 
in prevention programmes, in particular parents 
and families of “at risk” children, and that they 
have access to factual preventative materials. In this 
context, the Steering Group notes that a number 
of LDTF measures have focussed on parents of ‘at 
risk’ young people and families of drug misusers 
– however, there are continuing gaps in support for 
parents in non-LDTF areas. Phase 2 of the National 
Drugs Awareness Campaign (see para 4.11 below) 
was targeted specifically at parents and featured 
amongst other things, a television, radio and print 
advertising campaign, specific parent-focussed 
information on the website and a ‘Parent’s Guide 
to Drugs’ information leaflet. The Steering Group 
found, however, that despite the availability of this 
material there is often confusion amongst parents 
and families as to how best to access information 
regarding drugs. In the circumstances, the Group 
considers that factual preventative information for 
parents and families should be made available in 
locations such as Garda stations, libraries, health 
centres and other public offices.
4.8 In line with action 43 of the Strategy, the 
Departments of Education & Science and Health 
& Children have developed and disseminated 
guidelines on the preparation of substance use 
policies for schools to assist them in managing 
issues relating to drug misuse. Returns to the 
Department of Education & Science indicate that 
over 50% of all schools had adopted substance 
use policies by mid 2004. The Group found, 
however, that there are still practical problems in 
both developing and implementing such policies 
in some schools. In this context, the Steering 
Group notes that the Department of Education & 
Science will shortly be conducting a review of the 
process of developing and implementing substance 
use policies. Notwithstanding the findings of the 
review which are expected by the end of 2005, the 
Steering Group considers that it is imperative that a 
mechanism is put in place to track the development 
of substance use policies in schools and that an 
annual progress report is produced in this regard. In 
addition, the Group considers that the development 
and implementation of such policies in all LDTF 
area schools by the end of the 2005/06 academic 
year is a key priority going forward.
4.9 With regard to programmes in non-school based 
settings, action 37 of the Strategy stipulates that 
actions 31-35 (which deal primarily with school 
based prevention programmes) should also apply in 
non-school settings8. This is particularly important 
in that this sector deals with young people from 
more disadvantaged backgrounds who are at a 
higher risk of early school-leaving and drug misuse.
4.10 The Steering Group found that while there 
have been important strides in developing non-
school based programmes in recent years, there may 
be continuing gaps and also a lack of consistency in 
the approaches adopted by the different agencies. 
In the circumstances, the Steering Group considers 
that a working group should be set up – under the 
aegis of the Department of Education & Science 
– that would examine this area, identify ongoing 
gaps and develop guidelines and models of best 
practice for the implementation of substance use 
programmes in non-school settings. The working 
group should include representatives of the relevant 
Departments (Health & Children, Justice, Equality 
& Law Reform) as well as the Prison Service, the 
HSE and the community & voluntary sectors. In 
their deliberations, the working group should be 
particularly conscious of the needs of high risk 
groups such as foreign nationals, young offenders, 
Travellers and gay/lesbian/bisexual young people.
4.11 There has been considerable progress 
in relation to action 38 which calls for the 
development of a National Drugs Awareness 
Campaign highlighting the dangers of drugs. A 
three-year campaign was launched in May 2003 and 
to date, has been conducted in three phases:
■ Phase 1 – was aimed at the general population 
and featured an advertising campaign plus a 
supporting website, an information leaflet and a 
helpline;
■ Phase 2 – was targeted specifically at parents 
and featured a television, radio and print 
advertising campaign, a helpline, specific 
parent-focussed information on the website, 
a ‘Parent’s Guide to Drugs’ information leaflet 
and a nationwide road-show which aimed to 
answer parents questions about drugs and their 
children; and
■ Phase 3 – was targeted at cocaine users in 
the 18-35 year age group. This phase has also 
focussed on public relations activities and has 
achieved a high level of media awareness.
8  In general, these include programmes for under 18 year olds run through, for example, Youthreach, FÁS Community Training Workshops 
and VTOS (Vocational Training Opportunities Scheme) as well as youth diversionary programmes funded through the LDTFs, the YPFSF, 
the Garda Síochána, the National Youth Health Programme (NYHP), Senior Traveller Training Centres and the Irish Prison Service. 
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The focus of further phases of the campaign is 
currently being considered.
4.12 The Steering Group notes the importance of 
youth work in engaging with young people in a 
non-school setting, particularly those most at risk. In 
general, youth work aims to enhance the personal 
and social development of young people through 
their voluntary participation in programmes and 
activities that are complementary to their formal, 
academic and vocational education and training. In 
this way, it is seen as a mechanism through which 
to engage with young people involved in, or at risk 
of becoming involved in, drug misuse. Among the 
approaches used are activities and programmes 
dealing with the welfare and well-being of the 
individual(s) involved, the promotion of issue-
based activities, recreational and sporting activities 
and creative, artistic and cultural or language-
based programmes and activities. Through these 
approaches, the aim is to engage with the young 
people, and by their interaction with the youth 
workers and the volunteers involved, to help and 
support them to engage in a more meaningful way 
with the issues they face in their lives.
4.13 In this context, action 3 of the Strategy looks 
at the issue of alternatives to drug misuse for 
young people and the need to prioritise LDTF areas 
in funding programmes such the Young Peoples 
Facilities & Services Fund (YPFSF), the Sports 
Capital Programme and other such initiatives. 
The YPFSF, in particular, continues to target LDTF 
areas and to date, approximately €85m has been 
allocated, primarily to the 14 LDTF areas to support 
over 450 services and facilities projects, aimed at 
“at risk” young people in the 10 -21 age group. In 
this context, access by the Fund’s target group, 
particularly to the larger youth and community 
facilities being put in place though the YPFSF, is a 
key issue and one that is being actively monitored 
by the Fund’s National Assessment Committee 
(NAC). Overall, the Steering Group considers 
that the expansion of the Fund to other areas of 
similar need, outside of the LDTFs, needs to be 
actively progressed and notes that the work that is 
ongoing by the NDST regarding the identification 
of future Task Force areas is relevant in this regard. 
In addition, the Group believes that targeting 
potentially high risk groups, such as foreign national 
young people, should be a priority area for the Fund 
in the future.
4.14 An issue of ongoing concern to the Steering 
Group is the use of school facilities outside of 
school time and school holidays for community 
education and recreation purposes – particularly 
those located in disadvantaged areas. While some 
schools make their premises available to local clubs 
and groups, the Group considers that, in general, 
there is significant under-usage of such valuable 
community facilities and that ways of addressing the 
issues currently preventing/limiting such usage (e.g. 
insurance, health and safety) need to be addressed. 
While it is recognised that this is essentially a matter 
for boards of management and trustees of schools, 
the Steering Group welcomes the recent circular 
from the Department of Education & Science 
encouraging schools to allow community access to 
their premises outside of school hours. The Group 
also notes that this issue is being considered at 
present by the NAC and that the Committee will 
be developing proposals in this regard which will 
be brought to the IDG for consideration as soon as 
possible.
4.15 The Steering Group notes that one of the 
main actions identified in the Strategy (action 29) 
– publishing and implementing a policy statement 
on education and auditing levels of support in 
LDTF areas – has not been completed. One of the 
main reasons for the delay is the review currently 
being conducted by the Department of Education & 
Science on its approach to educational disadvantage. 
The Department intends that the outcome of this 
review will provide the framework for policies of 
educational supports at LDTF level. The Steering 
Group notes that the Department expects to be able 
to complete a map of schools serving LDTF areas 
and an audit of supplementary supports available 
through LDTFs by the end of 2005.
4.16 The Steering Group emphasises again the 
importance of data collection and the use of 
administrative data to contribute to programme 
evaluation and the development of evidenced based 
policy-making. In this regard, efforts should be made 
by all agencies involved in prevention to gather data 
on their activities at both local and national level.
KEY ISSUES EMERGING
4.17 As outlined at the beginning of this chapter, 
considerable progress has been made across the 
16 actions in the prevention pillar. However, the 
Steering Group has identified four key issues which 
will need to be addressed over the remaining 
lifetime of the Strategy up to 2008. The Group 
believes that this can be done through replacing or 
amending six existing actions in the Strategy and 
developing two new actions as outlined below:
1.  ISSUE: Substance use policies in schools 
– while a significant number of schools now 
have substance use policies in place, there 
is a need to monitor the development and 
implementation of such policies.
 Recommendations of Steering Group:
■ Substance use policies should be developed 
and implemented in all LDTF area schools 
by the end of the 2005/06 academic year 
(Action 43 replaced);
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■ A mechanism to monitor the development of 
substance use policies in all schools should be 
put in place and should report annually (Action 
43 replaced).
 Department/Agency responsible: 
Department of Education & Science
2.  ISSUE: Implementation of SPHE – where 
such programmes are in place, the practice 
of implementing them can vary significantly 
between schools. Equally, there can be a lack of 
prioritisation by management in some schools of 
the implementation of the programmes.
 Recommendations of Steering Group:
■ Appropriate and ongoing training and 
support services should be put in place on a 
nationwide basis for teachers to deliver the 
SPHE (Action 31 amended);
■ The supports provided to LDTF area schools 
through the Walk Tall Support Service 
should be extended to other areas of 
disadvantage (Action 32 amended);
■ Schools at primary and post-primary levels 
should further prioritise the implementation 
of school based prevention programmes 
within existing timetables (Action 33 
amended);
■ Prevention education should be part of 
the curriculum for student teachers (New 
Action).
 Department/Agency responsible: 
Department of Education & Science and Health 
Service Executive
3.  ISSUE: Prevention programmes in non-
school settings – while there has been progress 
in developing non-school based programmes 
in recent years, there are gaps and a lack of 
consistency in terms of how the programmes are 
delivered by the different agencies.
 Recommendation of Steering Group:
■ A working group should be established 
– under the aegis of the Department of 
Education & Science – to examine this area, 
to identify ongoing gaps and to develop 
guidelines and models of best practice 
for the implementation of substance use 
programmes in non-school settings. The 
group should report by January 2006 
(Action 37 amended).
 Department/Agency responsible: 
Department of Education & Science  
4. ISSUE: Supports for parents & families 
– while there have been positive developments 
in this area, there is often confusion amongst 
parents and families as to how best to access 
information regarding substance misuse. The 
role of the HSCL Scheme also needs to be 
strengthened.
 Recommendations of Steering Group:
■ Factual preventative information for parents 
and families in dealing with substance 
misuse should be more easily accessible in 
appropriate locations such as Garda Stations, 
libraries, health centres and other public 
offices (Action 35 replaced);
■ The role of the Home School Community 
Liaison Scheme should be further 
strengthened through the provision of 
additional resources. In particular, there is 
a need to expand the engagement of HSCL 
with families, particularly those dealing with 
drug misuse (New action).
 Department/Agency responsible: 
Department of Education & Science and the 
Health Service Executive
KEY PERFORMANCE INDICATORS
4.18 Having considered the issue, the Steering 
Group proposes the following KPIs under the 
prevention pillar. These indicators replace the 
existing KPIs and concentrate on available data:
■ The 3 Source Capture-Recapture study estimate 
of opiate misusers, which will be released in 
2007, to show a stabilisation in terms of overall 
numbers and to show a reduction of 5% of the 
prevalence rate based on 2001 figures published 
in 2003;
■ The NACD Drug Prevalence survey, which will 
be released in 2007, to show a reduction of 5% 
of the prevalence rate of recent and current use 
of illicit drugs in the overall population based on 
2002/03 rate;
■ Substance use polices in place in 100% of 
schools; and
■ Early school leaving in LDTF areas reduced by 
10% based on 2005/06 rate.
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PROGRESS ON ACTIONS OF THE PREVENTION, EDUCATION AND AWARENESS PILLAR
No. Agency Action Progress
3 D/CRGA Continued provision of accessible, positive alternatives to 
drug misuse in areas where such misuse is most prevalent 
through the YPFSF and more generally, through arts and 
culture youth programmes, the schemes run by the Irish 
Sports Council and the facilities provided through funding 
under the Sports Capital Programme. These should be 
accessible and attractive to those most at risk of drug 
misuse and those from socially, educationally and culturally 
diverse backgrounds. In this regard, the LDTF areas should 
be prioritised. Specific efforts should also be made to 
ensure that the groups who are most at risk of drug misuse 
are actively engaged in recreational activities at local level.
Completed or 
Ongoing Task
29 D/E&S Publish and implement a policy statement on education 
supports in LDTFs, including an audit of the current level of 
supports by end 2001.
Nominate an official to serve as a member of each Task 
Force.
Set up a group in the Department to discuss cross-cutting 
issues.
Progress made/
more work 
underway
30 D/E&S To prioritise LDTF areas during the establishment and 
expansion of the services of the National Educational 
Welfare Board.
Completed or 
Ongoing Task
31 D/E&S, 
HPU & HBs
To put in place by end 2001, mechanisms which will 
support, enhance and ensure the delivery of school-based 
education and prevention programmes in all schools 
nationwide over the next three years.
Completed or 
Ongoing Task
32 D/E&S, 
HPU & HBs
To implement ‘Walk Tall’ and ‘On My Own Two Feet’ 
Programmes in all schools in the LDTF areas, in the context 
of the SPHE programme during the academic year 2001/02.
Completed or 
Ongoing Task
33 D/E&S, 
HPU & HBs
To deliver the SPHE Programme in all second-level schools 
by September 2003.
Completed or 
Ongoing Task
34 (A) D/E&S, 
HPU & HBs
To complete the evaluation of the ‘Walk Tall’ and ‘On My 
Own Two Feet’ Programmes by end 2002 and to continue 
to evaluate the programmes in order to establish whether 
they need to be augmented or whether there is a need for 
alternative programmes to address key gaps.
Completed or 
Ongoing Task
34 (B) Schools should encourage the participation of parents 
on such programmes where appropriate. In particular, 
mechanisms for engaging the parents of at-risk children 
in programmes should be examined with a view to 
establishing models of best practice.
Progress made/
more work 
underway
35 D/E&S, 
HPU & HBs
To ensure that parents have access to factual preventative 
materials which encourage them to discuss the issues of 
coping with drug misuse with their children.
Completed or 
Ongoing Task
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No. Agency Action Progress
36 D/E&S To ensure that every second level school has an active 
programme to counter early school leaving with particular 
focus on areas with high levels of drug misuse.
Completed or 
Ongoing Task
37 D/E&S, 
HPU
Recommendations 31-35 to apply equally to the non-school 
education sector.
Progress made/
more work 
underway
38 D/H&C To develop and launch an ongoing National Awareness 
Campaign highlighting the dangers of drugs. The campaign 
should promote greater awareness and understanding of 
the causes and consequences of drug misuse, not only to 
the individual, but also to his/her family and society in 
general.
Completed or 
Ongoing Task
42 D/E&S,  
D/H&C
To ensure that the design and delivery of all preventive 
programmes are informed by ongoing research into the 
factors contributing to drug misuse by particular groups. 
The programmes should also include the development of 
initiatives aimed at equipping parents of at-risk children 
with the skills to assist their children to resist drug use or 
make informed choices about their health, personal lives 
and social development.
Progress made/
more work 
underway
43 D/E&S,  
D/H&C
To develop guidelines, in co-operation with the Health 
Boards to assist schools in the formation of a drugs policy 
and ensure that all schools have policies in place by 
September 2002.
Progress made/
more work 
underway
95 LDTFs/
RDTFs
Community-based initiatives to raise awareness. Completed or 
Ongoing Task
96/97 LDTFs/
RDTFs
LDTFs/RDTFs to raise awareness of drug misuse including 
involving user groups.
Completed or 
Ongoing Task
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CHAPTER 5 
TREATMENT, 
REHABILITATION 
AND RISK 
REDUCTION 
PILLAR
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5 Treatment, 
Rhabilitation and Risk 
Reduction Pillar
OVERVIEW
5.1 The NDS includes 36 actions (see pages 40-
43 for details) which fall under the treatment, 
rehabilitation and risk reduction pillar. The delivery 
of services under this pillar involves a complex 
network of statutory and non-statutory agencies 
working in partnership. The principal agencies 
involved are the Department of Health & Children; 
the Health Service Executive (HSE); the Prison 
Service; FÁS; the Probation and Welfare Service; 
Local Authorities; the LDTFs and a wide range of 
community and voluntary bodies. Of the actions 
under this pillar, nine are completed and/or 
ongoing (shown in green). There have been varying 
degrees of progress made on a further twenty 
four (shown in yellow), while, for various reasons, 
considerably more progress has to be made on 
three actions (shown in blue).
5.2 In reviewing the provisions in the Strategy 
in relation to treatment, the Steering Group is 
conscious of the variance in prevalence of drug 
misuse across the country, particularly between 
the Eastern region (former the ERHA area) and the 
rest of Ireland. Heroin and other problematic drug 
use is still most prevalent in the Eastern region, and 
accordingly, services have been in greater demand 
and have developed at a faster rate than in other 
parts of the country. This has been the background 
to the Steering Group’s considerations in its review 
of treatment services.
5.3 In reviewing the ongoing work under this pillar, 
the Steering Group examined a range of issues and 
believes that significant progress has been made 
in relation to a number of actions in this field. In 
particular, there has been a considerable expansion 
in the number of methadone treatment places 
(action 45). The Strategy set a target of a minimum 
number of treatment places of 6,500 by end 2002. 
This target has been surpassed with end March 
2005 figures standing at 7,390 treatment places. 
In addition, there has also been an expansion in 
the numbers of clinics involved in delivering the 
service, with an 18% increase since December 2000 
from 56 to 66, of which 7 are located outside the 
old ERHA region.
5.4 The Group is aware that there are difficulties 
nationwide in the recruitment of new 
pharmacists and GPs (action 56) into the 
methadone protocol. Outside the Dublin area, there 
is a shortage of GPs that are sufficiently trained to 
commence clients in treatment under the protocol9. 
There are also problems in some areas in relation 
to engaging pharmacists to operate the protocol. 
In the greater Dublin area, while there have been 
increases in the numbers of GPs participating in 
recent years, there continues to be a shortage in 
some areas which prevent clients from availing 
of local services. The Steering Group believes 
that to facilitate the successful implementation 
of the Strategy, greater involvement of GPs and 
pharmacists is essential.
5.5 The Steering Group notes that the voluntary 
and community sectors have made an important 
contribution to expanding the range of treatment 
services available and to increasing the number 
of counsellors and project workers involved in 
drug services. The Group notes that it is currently 
not open to those sectors to employ medical 
staff directly although it is not clear to the Group 
why this is the case. Given the complexity of this 
issue, the Group recommends that the Methadone 
Implementation Committee10 should be asked to 
examine this matter and to report to the IDG by 
the end of 2005. The Committee should look at the 
potential for voluntary services to employ medical 
staff directly as a means of improving treatment 
access and continuity of care for their clients.
5.6 The Steering Group notes that though there has 
been significant progress with regard to waiting 
lists, there are still critical time lags in accessing 
services in some locations in the Eastern region 
and in many locations in other parts of the country. 
Furthermore, the Steering Group recognises that 
for some groups (e.g. homeless people, Travellers) 
maintaining regular contact and providing support is 
crucial so that when treatment is available they are 
informed and ready to take up the place. It should 
also be acknowledged that to date, the experience 
has been that as services develop in any given area, 
more people come forward to access these services.
5.7 The Steering Group is also conscious of the call 
throughout the consultation process for greater 
availability of, and access to detoxification, at 
community and residential level. The Group is of 
the opinion that this provision should be expanded 
in line with international benchmarks, however, it 
is important to note that successful outcomes are 
more likely when linked with rehabilitation. In this 
context, increases in detoxification places, both 
community and residential, should be made in 
conjunction with increases in overall rehabilitation 
services.
9  Level 1 GPs cannot initiate clients into methadone treatment – this can only be done by Level 2 GPs.
10  The Methadone Implementation Committee was established to oversee the implementation of the regulatory changes of 1998 in 
relation to the prescribing of methadone. In 2002 the Committee was reconfigured in order to conduct an internal review of the 
operation of the Methadone Treatment Protocol.
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5.8 In relation to prisons, it is noted that the 
Irish Prison Service has made steady progress in 
implementing most of the actions set out for it in 
the NDS (actions 21-24), although the evaluation 
of the prison drugs strategy set for 2004 will not 
now begin until 2007. A key initial priority has 
been to develop the infrastructure to deliver 
treatment services and to achieve equivalence of 
care with community services. These enhanced 
provisions and institutional arrangements have 
brought improvements to the level and quality of 
services available within prisons (e.g. expansion 
of the provision of methadone programmes and 
increased number of drug-free units). The Steering 
Group is aware, however, that further improvements 
are required in prison treatment services 
– particularly in developing counselling services, 
enhanced methadone provision and post-release 
arrangements. The Prison Service is proactive 
in developing and improving these services and 
it is recognised that such developments must 
occur simultaneously with developments in the 
community and are mutually dependent. However, 
the Group recognises that there is still a gap in 
relation to sharing information between services, 
which would help in post-release arrangements. The 
Group notes that there have been developments 
in the area of case management which are 
ongoing and is of the view that these should be 
implemented as soon as possible and definitely 
before the end of 2006.
5.9 In addition, while acknowledging that the 
problem is most acute in prisons in the Eastern 
region, the Group believes that, as with drug 
treatment for the general community, treatment 
provision outside that area also needs to be 
expanded. The Group notes that the Department 
of Justice, Equality & Law Reform is in the process 
of finalising a prison drugs policy which will set the 
framework for developing future services. The fact 
that injecting drug use continues amongst drug 
misusers in the Irish prison population is a matter 
of great concern. The research available highlights 
the greater vulnerability of prisoners to infectious 
disease due to the higher prevalence of infection 
in the prison population. This merits continuing 
consideration in order to explore the many harm 
reduction approaches available for implementation 
within Irish prisons. The Steering Group notes that 
the increased provision of substitution treatment, 
vaccination programmes and education have 
been important steps in this regard and that this 
progress should be maintained. Finally, the Group 
also notes the absence of developed linkages 
between the Prison Service and key stakeholders 
such as the Drugs Strategy Unit of the Department 
of Community, Rural & Gaeltacht Affairs and the 
National Drugs Strategy Team in the development 
of drugs policy – and believes that this should be 
addressed.
5.10 The Steering Group is aware of the calls that 
have been made for further progress with regard to 
providing a range of medical and non-medical 
treatment services for problem drug users, 
including drug-free and detox facilities (related to 
action 48). The Group recognises that demand for 
these forms of treatment can vary and that analysis 
of this demand is hampered by the absence of more 
comprehensive timely data on the availability of 
alternative treatments to methadone. However, in 
line with the Strategy, the Group believes that there 
should be broad and accessible provision of these 
options and, in the regions where this is still not the 
case, their development should be prioritised for 
the remainder of the Strategy.
5.11 Delivering a seamless ‘client centred’ service 
is a particularly challenging action. In this context, 
the Group feels that the principle of continuum 
of care (action 47) i.e. smooth transition into 
appropriate and timely treatments and on through 
to rehabilitation, can play an important role. A 
range of treatment approaches is required in order 
to provide problem drug users with a planned 
programme of progression. In the opinion of 
the Group, this would provide drug misusers with 
planned timely access to a range of options from 
presentment, assessment, treatment and on to after-
care, rehabilitation and re-integration.
5.12 A number of other issues have arisen in the 
context of the availability of treatment, in particular 
the increased prevalence of cocaine misuse. 
The trend in this regard is noted in a number of 
sources including Garda figures and treatment 
statistics, as well as the NACD study11 which was 
published in 2003. In order to meet this challenge, 
the Steering Group believes that treatment services 
need to address the needs of cocaine-dependent 
patients and tailor and expand existing services in 
this regard. The Group notes that the Addiction 
Services in the HSE Eastern Region already provide 
a range of services to those presenting with 
problem cocaine use. The services are focussed on 
psychological support, counselling interventions and 
referral to appropriate residential services.
5.13 In this regard, the Group notes that there are 
different cohorts of users, which require different 
treatment approaches, in particular, opiate users 
who are also using cocaine. Unlike heroin, there is 
no substitution treatment for cocaine. In addition, 
the Group is of the opinion that the outcome of the 
evaluations of the pilot projects on cocaine12, which 
are being rolled out in 2005 should be carefully 
examined and the lessons implemented, particularly 
in the LDTF areas where the misusers most at risk 
11  An Overview of Cocaine Use in Ireland published by the NACD in December 2003.
12  Funding of almost €400,000 has been allocated by D/CRGA to support a series of pilot proposals aimed at tackling cocaine use in 
LDTF areas. The funding is being used for the training of frontline staff, the production of educational material and for a number of pilot 
treatment interventions with specific groups such as intravenous cocaine users, problematic intranasal cocaine users and problematic 
female cocaine users.
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are still located. The prevalence of crack cocaine, 
although still very low, will also need to be closely 
monitored. In line with the recommendations of 
the NACD report, it is also essential to continue to 
challenge the perception that cocaine use is not 
dangerous. In this context, the Steering Group is 
aware that more problem drug users are presenting 
with a range of drug dependencies, including 
alcohol, and that poly-drug use is increasingly the 
norm for this group. Effectively managing this trend 
presents a different set of challenges for the NDS, 
which need to be accommodated in the different 
approaches to treatment. Successfully treating 
this more diverse prevalence pattern will mean 
access to, and greater provision of, a wider range of 
treatment services.
5.14 The Strategy set out that a protocol should 
be developed for the treatment of under 18 
year olds presenting with serious drug problems 
(action 49). The Under 18s Working Group, chaired 
by the Department of Health & Children, felt that 
the complexity of individual needs in this client 
group implied that a protocol format could be 
overly restrictive, and that it was preferable to try 
to establish appropriate broad guidelines or models 
for treatment.13 The Group decided that treatment 
services for under 18 year old problem drug users 
should be based on a four-tiered approach from 
tier 1 which comprises services who engage with 
young people but who have no specialist expertise 
in adolescents or addictions through to tier 4 
– those services with specialist expertise in both 
adolescents and addiction and can provide brief 
intensive treatment. The Department of Health & 
Children has allocated funding of €500,000 to the 
HSE Eastern Region to fund the development of 
tier 3 teams (multi-disciplinary teams specialising 
in adolescents and addictions). The Steering Group 
believes that one of the priorities for the next phase 
of the Strategy is to advance the implementation of 
the Working Group’s Report. This will be monitored 
through the IDG on a regular basis.
5.15 In relation to action 54, the Steering Group is 
conscious that the Health Services consider that 
full-time childcare facilities within an addiction 
setting may lead to further stigmatisation of 
children of drug misusers. Therefore, implementing 
the action as it is currently phrased is not 
appropriate and it should be made more flexible. 
In this regard, the Steering Group believes that 
the Health Services should aim to provide more 
appropriate services where necessary, such as drop-
in play/creche areas rather than full-time facilities.
5.16 Research carried out by the NACD14 has raised 
the problems posed in delivering services to people 
with dual diagnosis (co-existence of mental health 
disorder and drug dependence). This particular 
cohort is more vulnerable to relapse, homelessness 
and suicide and in this regard, the Group welcomes 
the examination of joint protocols by the Advisory 
Sub-Group on Dual Diagnosis as part of the Expert 
Group on Mental Health which was established 
in August 2003 to prepare a new national policy 
framework for the mental health services.
5.17 The Steering Group also welcomes the drafting 
of service user charters by many of the Health 
Services as outlined in action 46. However, the 
Group is of the opinion that, in the future, where 
this is not already taking place, services should 
consult more widely with service users in the 
drafting of these documents.
5.18 The issue of preventative strategies in relation 
to drugs overdose was also raised during the 
course of the review. This is an area of concern 
for the Steering Group who believe that a national 
approach should be taken to this matter with 
appropriate preventative strategies being put in 
place and evaluated.
5.19 A striking feature of the consultation process 
was the numerous calls that were made for the 
development of a more comprehensive and inter-
linked approach to rehabilitation under the NDS. 
Furthermore, there were strong and consistent calls 
for rehabilitation to be made the “fifth” pillar of 
the Strategy, given its overall importance for drug 
misusers in terms of “moving on” and, ultimately, 
re-integrating them into society. While there is a 
lack of understanding around what is meant by 
rehabilitation, in general, it is seen as embracing a 
wide range of services (e.g. personal development, 
training, community integration, access to housing, 
access to employment etc.). In Ireland, there are 
a number of agencies currently involved in the 
provision of rehabilitation services, including the 
Health Services, FÁS and the community and 
voluntary sectors.
5.20 In this regard, the Steering Group is conscious 
of the key contribution FÁS has made to the NDS 
in relation to rehabilitation through the ring-fencing 
of CE places for drug-related projects. These CE 
places have served as an important mechanism for 
engaging drug users in treatment and rehabilitation 
programmes. However, the Group notes that a 
number of issues arise in this context, including the 
need to accommodate the needs of the Regional 
Drugs Task Forces and the cap of three years as a 
limit on the time a participant can remain on CE. 
In addition, discrepancies in how drugs projects 
are dealt with from area to area were also noted 
e.g. some schemes were dedicated Drugs Task 
13  The Under 18 Group undertook a number of initiatives including an examination of the legal issues surrounding treatment, a review of 
relevant literature, an analysis of trends in drug misuse by children and adolescents, a review of services and service gaps nationally, the 
establishment of focus groups of service users within and outside the ERHA region and a review of the treatment issues raised by its 
deliberations.
14  Mental Health and Addiction Services and the Management of Dual Diagnosis in Ireland published by the NACD in November 2004.
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Force projects where almost all participants were 
specially designated as having had substance 
misuse problems, while in others, there were 
dedicated places in ‘mainstream’ CE schemes. In 
addition, an evaluation of CE schemes15 has recently 
been completed and highlighted the need for 
inter-agency gaps to be addressed if rehabilitation 
services are to be improved.
5.21 In considering this issue, the Steering Group 
is conscious of the need to strengthen and expand 
the Strategy’s rehabilitation provisions – particularly 
in light of the significant and ongoing expansion 
in treatment provision in recent years (actions 48, 
57 & 74 primarily). Equally, however, the Group is 
conscious that there are many different views and 
interpretations as to what constitutes rehabilitation 
ranging from therapeutic approaches on the one 
hand to training and social re-integration on the 
other (as outlined in paragraph 5.19 above). The 
Group is also conscious that the NACD will be 
examining this area during 2005 as part of their new 
research work programme. In the circumstances 
and given the overall importance of this area in 
the NDS in the future, the Steering Group supports 
the proposal that rehabilitation should be made 
the fifth pillar of the Strategy. However, the Group 
believes that further work needs to done before a 
comprehensive policy – and individual actions – on 
rehabilitation can be developed. Accordingly, it is 
recommended that a working group be established 
under the aegis of the Department of Community, 
Rural & Gaeltacht Affairs to comprehensively 
examine this area and to develop an integrated 
rehabilitation policy. The group should include 
representatives of the key agencies currently 
involved in delivering rehabilitation services and 
should examine the broad range of issues that 
impact on the provision of rehabilitation, including 
the long-term supports that are required to enable 
drug misusers to re-integrate into the labour 
market. The working group should have regard 
to the findings of the evaluation of CE carried 
out in 2004 (see paragraph 5.20 above) and the 
work to be done in 2005 by the NACD, as well EU 
and international best practice in this area. The 
group should report to the IDG and the Cabinet 
Committee on Social Inclusion by the end of 2005 
on the appropriate actions to be implemented.
5.22 Notwithstanding the work of the group to be 
established, the Steering Group is of the opinion 
that the three year cap for CE places needs to 
be applied flexibly in the case of recovering drug 
misusers.
5.23 In relation to harm reduction approaches16 
– including needle exchange and other injecting 
paraphernalia (actions 62 and 63), the Group feels 
that, in light of the increase in the incidence of 
hepatitis C and the ongoing prevalence of HIV, 
higher priority should be given to the relevant 
actions in the Strategy. This is supported by the 
available data that indicates that sharing injecting 
paraphernalia continues amongst drug misusers. 
The Group is also conscious that it is much easier 
to transmit blood-borne diseases such as hepatitis 
C through shared injecting paraphernalia than it 
is with HIV. Accordingly, drug misusers are not 
adequately protected through measures designed 
to combat the spread of HIV. The Steering Group 
is of the opinion that further efforts are needed 
to identify the risk behaviours of Irish drug users 
that contribute to the higher prevalence rates (e.g. 
hepatitis C) than EU norms and to raise awareness 
amongst users in this regard. Furthermore, 
enhanced training for service providers on this issue 
should be made available.
5.24 In this regard, the Steering Group advocates 
the expansion of harm reduction services, especially 
needle exchanges, to improve access and availability 
in the evenings and weekends and in areas of 
greatest need such as the eastern region. The Group 
is of the opinion that a range of approaches may be 
necessary to achieve this and the Health Services 
should prioritise and develop whatever is most 
appropriate to the area concerned. In particular, the 
Group believes that harm reduction services should 
have the flexibility to cater for the provision and/or 
exchange of a range of drug use paraphernalia so 
as to reduce the risk of contracting drug-related 
infectious diseases. The Steering Group also 
understands that the action regarding the collection 
and safe disposal of injecting equipment (action 69) 
is now being progressed but that considerably more 
work is required to advance its implementation.
KEY ISSUES EMERGING
5.25 As outlined at the beginning of the chapter, 
significant progress has been made across the 36 
actions under the treatment pillar. However, the 
Steering Group has identified six key issues that 
need to be addressed in the period up to 2008. 
This can be done through a mixture of replacing or 
amending existing actions and developing two new 
actions which are set out below:
1. ISSUE – Availability of treatment options 
– given the increased prevalence of poly-drug 
use, including cocaine, the availability and range 
of treatment options should continue to be 
increased.
 
15  A Review of Drugs Task Force Project Activity for FÁS Community Employment and Job Initiative Participants, Dr. Alan Bruce, July 2004 
(unpublished).
16  Harm Reduction approaches focus on minimising the health, personal and social harms associated with drug use such as the spread of 
blood-borne diseases. Harm reduction programmes typically include a range of interventions, which on a continuum, commence with 
communication with drug users and the general public and move to the prescription of drug substitution treatment (A Review of Harm 
Reduction Approaches in Ireland and Evidence from the International Literature published by NACD in May 2004). 
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 Recommendations of the Steering Group:
■ An audit of the current availability of 
treatment options should be carried out 
which should include an assessment of 
treatment needs and propose ways of 
tracking ongoing developments. The audit 
should be completed by mid-2006 (New 
Action).
■ In the context of increased poly-drug 
use, including cocaine and other drugs 
of dependence, increasing the availability 
and range of treatment options, including 
detoxification, should continue to be 
prioritised. This work should take on board 
the lessons of the pilot cocaine projects 
currently being rolled out in LDTF areas 
(Action 48 amended).
 Department/Agency responsible: Health 
Service Executive
2.  ISSUE – Rehabilitation provision within the 
Strategy – the Steering Group believes that 
rehabilitation should be the fifth pillar of the 
Strategy. In this context, however it was felt that 
a working group should be set up to develop 
the pillar in terms of an integrated rehabilitation 
provision.
 Recommendations of the Steering Group:
■ Rehabilitation should become the fifth 
pillar of the National Drugs Strategy. In 
this context, a working group should be set 
up to develop an integrated rehabilitation 
provision. The group, to be chaired by 
the Department of Community, Rural 
& Gaeltacht Affairs, should report to 
the IDG and the Cabinet Committee on 
Social Inclusion by the end of 2005 on the 
appropriate actions to be implemented 
(New Action).
 Department/Agency responsible: 
Department of Community, Rural & Gaeltacht 
Affairs
3.  ISSUE – Treatment for Under 18s – the 
Working Group has completed its work and 
the challenge for the remaining period of the 
Strategy is to implement the recommendations 
arising from the Working Group’s report.
 Recommendations of the Steering Group:
■ The guidelines agreed by the Working Group 
on treatment for under 18s should be fully 
implemented by end 2007, with priority 
given to areas of most need (Action 49 
replaced).
 Department/Agency responsible: Health 
Service Executive
4. ISSUE – Development of needle exchange 
and related harm reduction service 
provision – in the light of the increase in 
the incidence of hepatitis C and the ongoing 
prevalence of HIV, higher priority needs to be 
given to the actions in the Strategy in relation to 
harm reduction approaches – including needle 
exchange and exchange of other injecting 
paraphernalia.
 Recommendations of the Steering Group:
■ The provision of needle exchange and 
related harm reduction services should 
be expanded in order to ensure wider 
geographic availability and availability at 
evenings and weekends, concentrating at 
first on areas of highest need (Action 62 
replaced).
 Department/Agency responsible: Health 
Service Executive
5.  ISSUE – Target for treatment provision 
– while there have been significant 
improvements in treatment provision in recent 
years, in the remaining phase of the Strategy 
the concentration should be on providing 
appropriate treatment (covering all treatments) 
no later than one month after assessment.
 Recommendations of the Steering Group:
■ Appropriate treatment should be provided 
to problem drug users no later than one 
month after assessment. This target should 
be met by end 2007 (Action 44 amended).
 Department/Agency responsible: Health 
Service Executive
6.  ISSUE – Participation of GPs and 
pharmacists – the importance of increasing GP 
and pharmacist participation in the provision of 
methadone treatment needs to continue to be 
prioritised.
 Recommendations of the Steering Group:
■ The numbers of GPs (in particular Level II 
GPs) and pharmacists participating in the 
methadone protocol, particularly in the 
areas of most need, should continue to be 
increased (Action 56 replaced);
■ The Methadone Implementation Committee 
should examine the issue of the voluntary 
and community services employing medical 
staff directly and they should report to 
the IDG by the end of 2005 (Action 56 
replaced).
 Department/Agency responsible: Health 
Service Executive/Department of Health & 
Children
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KEY PERFORMANCE INDICATORS
5.27 In the case of the treatment pillar, the Steering 
Group proposes the following KPIs to replace the 
existing indicators set out in the NDS:
■ 100% of problematic drug users accessing 
treatment within one month after assessment;
■ 100% of problematic drug users aged under-18 
accessing treatment within one month after 
assessment;
■ Harm reduction facilities available, including 
needle exchange where necessary, open 
during the day, and at evenings and weekends, 
according to need, in every local health office 
area; and
■ Incidence of HIV in drugs user stabilised based 
on 2004 figures.
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PROGRESS ON ACTIONS OF THE TREATMENT, REHABILITATION AND RISK REDUCTION PILLAR
No. Agency Action Progress
21 Prison 
Services
To continue to implement the recommendations of the 
Steering Group on Prison-Based Drug Treatment Services 
as a priority and to implement proposals designed to end 
heroin use in prisons during the period of the Strategy. 
Completed/Ongoing 
Task
22 Prison 
Service
To expand prison-based programmes with the aim of 
having treatment and rehabilitation available to those who 
need them including drug treatment programmes, which 
specifically deal with the reintegration of the drug using 
offender into the family/community.
Progress made/more 
work underway
23 Prison 
Service
To commission and carry out an independent evaluation 
of the overall effectiveness of the Prison Strategy by mid 
2004. The review should cover all aspects of drug services 
in prisons including research on the levels and routes of 
supply of drugs in prisons.
Considerably more 
progress required
24 Prison 
Service
To expand the involvement of the community and 
voluntary sectors in prison drug policy via the ongoing 
development of the Local Prison Liaison Groups and the 
formal meetings between the sectors and the Steering 
Group on Prison-Based Drug Treatment Services.
Progress made/more 
work underway
26 D/EHLG To monitor and evaluate homelessness initiatives in relation 
to drugs issues in the context of the Homeless Strategy and 
particularly, in relation to the Dublin Action Plan.
Completed/Ongoing 
Task
39 D/H&C To ensure that adequate training for health care and 
other professionals engaged in the management of 
drug dependency is available, including, if necessary, 
arrangements with third level institutions and other bodies.
Progress made/more 
work underway
40 D/H&C To consult all treatment and rehabilitation providers in 
order to ensure that performance indicators, used in the 
evaluation of services, accurately and consistently reflect 
the needs of specific areas i.e. performance indicators 
should reflect the reality of the drug problem locally.
Progress made/more 
work underway
41 D/H&C To oversee implementation of the recommendations of the 
Benzodiazepine Working Group, which is due to complete 
its work by end June 2001, as part of the overall strategy of 
quality improvement of current services.
Progress made/more 
work underway
44 HEALTH 
BOARDS
To have immediate access for drug misusers to professional 
assessment and counselling by health board services, 
followed by commencement of treatment as deemed 
appropriate, not later than one month after assessment.
Progress made/more 
work underway
45 HEALTH 
BOARDS
To increase the number of treatment places for opiate 
addiction to 6,000 by the end of 2001 and to a minimum of 
6,500 by the end of 2002.
Completed/Ongoing 
Task
46 HEALTH 
BOARDS
To develop and put in place by end 2002 a service-users 
charter specific to treatment and rehabilitation facilities 
which would lead to a greater balance in the relationship 
between the service user and the service provider.
Progress made/more 
work underway
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No. Agency Action Progress
47 HEALTH 
BOARDS
To base plans for treatment services on a “continuum 
of care” model and a “key worker” approach to provide 
a seamless transition between each different phase of 
treatment.
Progress made/more 
work underway
48 HEALTH 
BOARDS
To have in place, in each Health Board area, a range of 
treatment and rehabilitation options as part of a planned 
programme of progression for each drug misuser, by 
end 2002. This approach will provide a series of options 
for the drug misuser, appropriate to his/her needs and 
circumstances and should assist in his/her re-integration 
back into society.
Progress made/more 
work underway
49 HEALTH 
BOARDS
To develop a protocol, where appropriate, for the 
treatment of under 18 year olds presenting with serious 
drug problems especially in light of the legal and other 
dilemmas which are posed for professionals involved in 
the area. In this context, a Working Group should be 
established to develop the protocol. The Group should also 
look at issues such as availability of appropriate residential 
and day treatment programmes, education and training 
rehabilitative measures and harm reduction responses for 
young people. The Group should report by mid 2002.
Completed/Ongoing 
Task
50 HEALTH 
BOARDS
To develop, in consultation with the NACD, criteria to 
ensure that all State-funded treatment and rehabilitation 
programmes accord with quality standards as set out by the 
Health Boards.
Progress made/more 
work underway
51 HEALTH 
BOARDS
To have a clearly co-ordinated and well publicised plan 
in place for each Health Board area by end 2002 for the 
provision of a comprehensive and locally accessible range 
of treatments for drug misusers, particularly for young 
people. The planning of such services to be linked to the 
national profile of drug misuse amongst young people and 
to the areas where usage is most prevalent. These plans to 
be implemented by end 2004.
Progress made/more 
work underway
52 HEALTH 
BOARDS
To produce and widely distribute a well publicised, short, 
easily read guide to the drug treatment services available in 
each Health Board area with contact numbers for further 
information and assistance.
Completed/Ongoing 
Task
53 HEALTH 
BOARDS
To require from 2002 that all Health Boards, in considering 
the location and establishment of treatment and 
rehabilitation facilities, develop a management plan in 
consultation with local communities. Existing examples 
whereby Health Boards have established monitoring 
committees with the local community to oversee the 
operation of treatment services have proven successful and 
should be replicated, where appropiate.
Completed/Ongoing 
Task
54 HEALTH 
BOARDS
To consider, as a matter of priority, how best to integrate 
childcare facilities with treatment and rehabilitation centres 
and how childcare can best be provided in a residential 
treatment setting. This should be done in conjunction with 
the Department of Justice, Equality & Law Reform.
Progress made/more 
work underway
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No. Agency Action Progress
55 HEALTH 
BOARDS
To explore immediately the scope for introducing greater 
provision of alternative medical and non-medical treatment 
types, which allow greater flexibility and choice. This 
may increase the number of drug misusers presenting for 
treatment as it is evident that a “one size fits all” approach 
is not appropiate to the characteristics of Irish drug misuse.
Progress made/more 
work underway
56 HEALTH 
BOARDS
To consider as a matter of priority, how to increase the 
level of GP and pharmacy involvement in the provision of 
treatment programmes.
Progress made/more 
work underway
57 HEALTH 
BOARDS
To oversee the development of comprehensive residential 
treatment models incorporating detoxification, intervention, 
pre-treatment, counselling, motivational work, therapeutic 
treatment and high quality rehabilitation for misusers who 
wish to become drug-free. Resources should continue to 
be targeted at the most efficient and effective of these 
services.
Progress made/more 
work underway
58 HEALTH 
BOARDS
To report to the NACD on the efficacy of different forms 
of treatment and detox facilities and residential drug-free 
regimes on an ongoing basis.
Completed/Ongoing 
Task
59 HEALTH 
BOARDS
To secure easy access to counselling services for young 
people seeking assistance with drug-related problems, 
especially given the correlation between suicide and drug 
misuse and the growing incidence of suicide amongst 
young people. 
Progress made/more 
work underway
60 HEALTH 
BOARDS
To ensure that treatment for young people includes family 
therapy and community integration phases, in order to 
encourage family involvement which is a crucial component 
in the treatment of young people. 
Progress made/more 
work underway
61 HEALTH 
BOARDS
To consider developing drop-in centres, respite facilities 
and half-way houses, where a clear need has been 
identified, as such facilities have been found to be useful in 
the prevention of relapse.
Considerably more 
progress required
62 HEALTH 
BOARDS
To review the existing network of needle exchange facilities 
with a view to ensuring access for all injecting drug 
misusers to sterile equipment.
Progress made/more 
work underway
63 HEALTH 
BOARDS
To pursue with the relevant agencies, as a matter of 
priority, the setting up of a Pilot Community Pharmacy 
Needle and Syringe Exchange Programme in the ERHA 
area, and in the event of a successful evaluation, the 
programme to be extended where required.
Considerably more 
progress required
64 HEALTH 
BOARDS
To continue to develop good practice outreach models, 
including mechanisms to outreach drug misusers who 
are not in contact with mainstream treatment or support 
agencies. A reduction in the level of drug-related 
deaths, particularly from opiate abuse, through targeted 
information, educational and prevention campaigns must 
be a key aspect of the Strategy.
Progress made/more 
work underway
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No. Agency Action Progress
66 HEALTH 
BOARDS
To consider the feasibility of new suitably trained peer-
support groups in the context of expanded provision. Peer-
support groups are a component of the existing Strategy 
and are regarded as an effective rehabilitative support.
Progress made/more 
work underway
68 HEALTH 
BOARDS & 
LAs
Liase re housing with LA to ensure access to housing for 
recovering drug users.
Completed/Ongoing 
Task
69 LAs & HBs To develop and implement proposals for the collection and 
safe disposal of injecting equipment.
Progress made/more 
work underway
71 CDBs To consider the needs of those areas that have high levels 
of drug misuse when drawing up city/countywide strategies 
for economic, social and cultural development.
Completed/Ongoing 
Task
74 FÁS To increase the number of training and employment 
opportunities for drug misusers by 30% by end 2004, in line 
with the commitment to provide such opportunities in the 
PPF and taking on board best practice from the special FÁS 
Community Employment Programme and the Pilot Labour 
Inclusion Programme.
Progress made/more 
work underway
75 FÁS To examine the potential to involve recovering drug 
misusers in Social Economy projects, and in other forms 
of vocational training. The ring-fencing of places within 
the FÁS Community Employment Programme has 
been an important element of the existing approach to 
rehabilitation.
Progress made/more 
work underway
76 FÁS To monitor the participation of recovering drug misusers on 
such programmes and to review their overall effectiveness. 
In this context, alternative models should be developed 
where appropriate.
Progress made/more 
work underway
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CHAPTER 6 
RESEARCH 
PILLAR
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6 Research Pillar
OVERVIEW OF PROGRESS
6.1 The NDS includes 5 actions (see page 49 
for details) under the research pillar relating 
to (i) specific pieces of work to be carried out 
by the National Advisory Committee on Drugs 
(NACD) (actions 98-100), (ii) returns by service 
providers to the Drug Misuse Research Division 
of the Health Research Board (action 65) and (iii) 
the development of an accurate mechanism for 
recording the number of drug-related deaths (action 
67). One of the actions (shown in green) has been 
completed while there has been varying degrees of 
progress made on all of the remaining four actions 
(shown in yellow).
6.2 The overall objectives of this pillar are to have 
available valid, timely and comparable data on the 
extent of drug misuse in Ireland, with a particular 
focus on marginalised groups, and to gain a greater 
understanding of the factors which contribute to 
Irish people, particularly young people, misusing 
drugs. This is being done through the development 
of more rigorous information based on quality 
research that will underpin the development of 
evidence based policy-making across each of the 
pillars. This chapter looks at progress to date across 
the five research actions and identifies a number of 
issues to be addressed in the period up to 2008.
6.3 Since its establishment in 2000, the NACD 
has produced a substantial body of work through 
its ongoing research programme. In relation to 
the specific actions set out in the NDS, it has 
commissioned a report on Harm Reduction (action 
100) which was published in 200417. Research will 
also be published on specific ‘at risk’ groups 
(action 98) such as homeless people (April 2005) 
and members of the Traveller Community. In 
addition, the NACD is conducting ongoing research 
into specific groups such as early school-leavers 
and sex workers. It has also commissioned a 
longitudinal study on treatment outcomes, 
known as ROSIE (action 99) which is ongoing.
6.4 Key prevalence information has also been 
provided through the NACD/DAIRU18 Drug 
Prevalence Survey 2002/2003 as well as the 3 
Source Capture Recapture Study (2003) which 
estimates the number of opiate users in Ireland. 
The Steering Group believes that these two pieces 
of research are vital in assessing trends in drug 
misuse in Ireland and that they should, therefore, be 
repeated before the end of the Strategy. The NACD 
has also published many other reports on identified 
research gaps, e.g. use of buprenorphine, lofexidine, 
naloxone, cocaine, cannabis, dual diagnosis, role of 
family support agencies etc. although the Steering 
Group notes that, currently, no mechanism exists 
for monitoring the implementation of the 
recommendations arising from these reports. This 
is an issue that the Steering Group considers needs 
to be addressed.
6.5 The Drug Misuse Research Division (DMRD) 
of the Health Research Board (HRB), which is an 
independent statutory body under the aegis of 
the Department of Health & Children, plays a key 
role in the area of monitoring and surveillance 
of drug treatment through its management 
of the National Drug Treatment Reporting 
System (NDTRS) – the national epidemiological 
database on treated problem drug use, which is 
compiled from the returns made by various service 
providers.19 Action 65 of the NDS provides that all 
treatment providers should co-operate in returning 
information on problem drug use to the DMRD. 
In this regard, it is noted that the situation has 
significantly improved regarding returns from the 
health services and a number of revisions have been 
made to the reporting system in order to improve 
its completeness, accuracy and usefulness. It is 
also noted that the Prison Service has not yet been 
included in the returns to the NDTRS, although 
the Group understands that this is being addressed 
bilaterally between the DMRD and the Prison 
Service.
6.6 Action 67 of the National Drugs Strategy calls 
for the development of an accurate mechanism for 
recording the number of drug-related deaths in 
Ireland. In this regard, the Departments of Justice, 
Equality & Law Reform, Health & Children and 
Community, Rural & Gaeltacht Affairs, the National 
Drugs Strategy Team and the HRB, in conjunction 
with the Central Statistics Office (CSO) and the 
Coroners’ Office, have been working on this action. 
Given its particular expertise, the DMRD has agreed 
to develop and host a National Drug-Related Death 
Index. In this context, the DMRD will publish an 
occasional paper during 2005 that will describe 
what is known about trends in drug-related deaths 
and deaths among drug users in Ireland and will 
begin the process of establishing the Index. The 
Steering Group views the development of such an 
index as a very important component of an overall 
strategy to reduce drug-related deaths and is of  
the opinion that it should be progressed as soon  
as possible.
17  A Review of Harm Reduction Approaches in Ireland and Evidence from the International Literature published by the NACD in May 2004.
18  DAIRU – Drug and Alcohol Information and Research Unit of Northern Ireland
19  The DMRD is the central point through which drug research data and information is channelled. In this context, it has developed the 
National Documentation Centre (NDC) on Drug Use, which holds 2,500 volumes on drug-related research published in Ireland and 
a number of key international publications. Funding for the NDC is provided by the Department of Community, Rural & Gaeltacht 
Affairs. In addition, the DMRD is the designated National Focal Point for European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), to which it makes annual reports based on the 5 key indicators of the EMCDDA – 1. extent and pattern of drug use in the 
general population; 2. prevalence of problem drug use; 3. demand for treatment by drug users; 4. drug-related deaths and mortality of 
drug users and 5. drug-related infectious diseases (HIV, hepatitis).
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6.7 The Steering Group is aware that a Drug Trend 
Monitoring System (DTMS) is being piloted by 
the NACD at present. The aim of the DTMS is to 
identify trends such as the spread of drugs such as 
heroin into new areas; the availability of new drugs; 
new patterns and combinations of drug use; and 
new drug user groups. Once the pilot is completed 
(in April 2005), a report will be submitted to the 
Cabinet Committee on Social Inclusion regarding 
the best way forward. The Steering Group is aware 
that the outcome of the pilot is not yet clear 
and that recommendations have yet to be made. 
However, the Group believes that a monitoring 
system, in whatever form it may take, could prove to 
be very valuable in terms of localised knowledge in 
the future.
6.8 The Central Methadone Treatment List 
(CMTL) is another important source of information 
and the Group is of the opinion that it would be 
improved by the provision of further information 
regarding entry and re-entry of clients and the 
length of time in treatment. The Group is aware that 
some work in this regard is ongoing. In addition, 
the Steering Group believes that details regarding 
the waiting lists in various regions should also be 
developed by the HSE as, currently, only data for 
the Eastern region is available.
6.9 Similarly, there are gaps in relation to 
information and data collection within the criminal 
justice system that, if filled, could prove useful 
to policy-makers. While the Garda Annual Reports 
provide a good breakdown in relation to drugs 
seizures by type and overall arrests for possession 
and supply, the information is not sub-divided 
into possession and supply offences broken down 
by drug. The new Courts Cases Tracking System, 
referred to in Chapter 3, will have additional 
information in relation to sentencing in drugs cases 
which will help to inform on the above issues. The 
Group also notes that research into drugs and crime 
is one of the priority areas for the NACD for their 
new work programme.
6.10 In reviewing progress under the research 
pillar, the Steering Group is conscious of the need 
for good quality data and research to support the 
implementation of the NDS. Both of the main 
players in the research field in Ireland – the DMRD 
and the NACD – fulfill distinct roles and have 
enhanced understanding about the drug situation 
in Ireland. The issue of their working relationship 
was examined in the review of the NACD20 carried 
out in 2004 and the Steering Group supports the 
recommendations made in that review for the 
establishment of closer contacts between them 
and believes that this would improve co-operation 
and coherence in the sector. The Steering Group is 
also conscious that the review concluded that the 
NACD was effective and providing value for money.
6.11 Currently, a range of different Departments 
and agencies such as the DMRD, NACD, Garda 
Síochána, Courts Service, the HSE, the Drug 
Treatment Centre Board and the voluntary sector 
produce data in the drugs field on an ongoing 
basis. The Steering Group believes that a report 
outlining the available data on the nature and 
extent of drug use in Ireland – separate from a 
report on the progress of the Strategy itself – should 
be produced. In this regard, the Group is conscious 
that the DMRD already produce an annual report 
on the drugs situation in Ireland for the EMCDDA. 
Accordingly, the Group believes that publication of 
the data contained in that report could fulfill this 
requirement. In this regard, the Drugs Strategy Unit 
will discuss this matter further with the DMRD and 
the Department of Health & Children.
6.12 An issue also raised during the course of 
the review was the need for localised and 
regionalised data on the nature and extent of drug 
misuse – in addition to national data – to allow 
for the planning of services at local and regional 
levels. There are a number of challenges involved 
in providing such data, including the fact that 
in a number of cases, areas covered by services 
providers are not co-terminus. For example, the HSE 
areas are different to the Garda districts which, in 
turn, do not correspond to LDTF areas. This makes 
it difficult to compare different data sources, but 
notwithstanding these issues, the Steering Group 
feels that developing localised and regionalised data 
is very important and must be actively progressed.
6.13 There are also issues around the actual 
commissioning and carrying out of local/regional 
research by, for example, LDTFs and RDTFs and 
the Steering Group notes the need to ensure 
that acceptable research standards are followed. 
In this regard, the Group is aware that it is very 
difficult to provide localised information from 
routine administrative data. In order to assist with 
developing localised knowledge at LDTF and RDTF 
level, it is noted that the NACD has agreed to 
facilitate a training workshop during 2005 on how 
to commission and manage research projects, with 
nominated participants from the different areas. 
Guidelines that will support groups undertaking or 
commissioning research will also be developed. In 
general, the Group notes that there is also a need 
for better use to be made of available information 
so that it is more accessible for policy-makers 
and other bodies such as LDTFs and RDTFs. This 
requires a commitment on the part of the different 
agencies to make the information they have more 
readily available.
KEY ISSUES EMERGING
6.14 The Steering Group notes that substantial 
progress has been made in relation to the 5 actions 
20 Review of the Work of the National Advisory Committee on Drugs (NACD), Talbot Associates, Management Consultants, May 2004
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under this pillar. Two key issues were highlighted 
during the course of the review, however, which if 
addressed, the Group believes will strengthen this 
pillar and add to its overall role within the Strategy. 
As these issues are not covered within the scope of 
the existing 5 actions of the Strategy, 2 new actions 
are being proposed, as outlined below.
1.  ISSUE: Monitoring the implementation of 
the recommendations in the NACD reports 
– currently there is no mechanism in place 
to track progress in implementing the NACD 
recommendations arising from their various 
reports.
 Recommendation of the Steering Group:
■ Monitoring the implementation of the 
recommendations arising from the NACD 
reports should become part of the NDS 
progress reports to the Cabinet Committee 
on Social Inclusion. Reporting on the NACD 
recommendations should be done annually 
(New Action).
 Department/Agency responsible: 
Department of Community, Rural & Gaeltacht 
Affairs
2.  ISSUE: Information available from the 
Central Methadone Treatment List – this 
could be improved by the provision of further 
information regarding entry and re-entry of 
clients and the length of time in treatment. In 
addition, details regarding the waiting lists in 
various regions should also be developed by 
the HSE as, currently, only data for the Eastern 
region is available.
 Recommendation of the Steering Group:
■ The CMTL should be developed by the 
provision of further information regarding 
entry and re-entry of clients and the length 
of time in treatment and this additional 
information should be made available on 
an annual basis. Waiting lists for treatment 
in the various regions should also be 
developed by the HSE (New Action).
 Department/Agency responsible: Drug 
Treatment Centre Board/Health Service 
Executive
KEY PERFORMANCE INDICATORS
6.15 As with the other pillars, the Steering Group 
proposes a number of KPIs in relation to research, 
to replace the existing indicators:
■ Eliminate all identified gaps in drugs research by 
mid 2008;
■ Publish an annual report on the nature and 
extent of the drug problem in Ireland, drawing 
on available data; and
■ Publish a report on progress being made in 
achieving the objectives and aims set out in the 
Strategy every two years.
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PROGRESS ON THE ACTIONS UNDER THE RESEARCH PILLAR
No. Agency Action Progress
65 HEALTH 
BOARDS
All treatment providers should co-operate in returning 
information on problem drug use to the Drug Misuse 
Research Division of the Health Research Board.
Progress made/more 
work underway
67 Coroners’ 
Office and 
CSO
Develop accurate mechanism for recording the number of 
drug-related deaths.
Progress made/more 
work underway
98 NACD To carry out studies on drug misuse amongst the at-risk 
groups identified e.g. Travellers, prostitutes, the homeless, 
early school-leavers etc. including de-segregation of data on 
these groups. It is essential that the individuals and groups 
most affected by drug misuse and those involved in working 
to reduce, treat and prevent drug misuse have immediate 
access to relevant statistical information.
Progress made/more 
work underway
99 NACD To commission further outcome studies, within the Irish 
setting to establish the current impact of methadone 
treatment on both individual health and on offending 
behaviour. Such studies should be an important tool in 
determining the long term value of this treatment.
Progress made/more 
work underway
100 NACD To conduct research into the effectiveness of new 
mechanisms to minimise the sharing of equipment e.g. non-
reusable syringes, mobile syringe exchange facilities etc. to 
establish the potential application of new options within 
particular cohorts of the drug using population i.e amongst 
younger drug misusers, within prisons etc.
Completed/Ongoing 
Task
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CHAPTER 7 
INSTITUTIONAL 
STRUCTURES OF 
THE NATIONAL 
DRUGS STRATEGY
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7 Institutional Structures 
of the National Drugs 
Strategy
7.1 The NDS contains 22 actions (see pages 58-59 
for details) relating to institutional structures. The 
Steering Group notes that 17 (shown in green) 
of the 22 actions have been completed or are 
ongoing tasks, although some were implemented 
considerably later than scheduled. Many of these 
actions are of a routine nature and form ongoing 
tasks for the life of the Strategy for the relevant 
Department or agency. In relation to the actions 
that have been completed, the Steering Group 
notes that the RDTFs have been established 
(actions 92-94) and the review of the NDST carried 
out and staff levels increased (action 83). Of the 
remaining five actions, the Steering Group notes 
that some progress has been made in relation to 
three of the actions (shown in yellow) while in the 
case of the remaining two actions, considerably 
more progress is required (shown in blue).
7.2 The Steering Group is cognisant that effective 
implementation of the NDS is closely linked to how 
well the institutional arrangements work. As a cross-
cutting area of public policy and service delivery, 
implementation of the NDS represents a significant 
institutional challenge. There are over 20 statutory 
agencies involved in delivering the Strategy, as well 
as multiple service providers and community and 
voluntary groups. The NDS recognises the specific 
issues and limitations in managing cross-agency 
collaboration. Its overall approach is to put workable 
inter-agency mechanisms in place to co-ordinate 
the activities of multiple statutory and non-statutory 
agencies to achieve the Strategy’s objectives. To 
facilitate this integration and co-ordination, a 
dedicated institutional framework is in place which 
interacts closely with all of the statutory and non-
statutory agencies involved in implementing the 
Strategy. Terms of Reference of the bodies which 
make up this framework are outlined in Appendix 
4. The Steering Group has reviewed the current 
institutional arrangements with a view to addressing 
gaps and clarifying roles.
7.3 The Group notes the continued valuable 
role that the LDTFs play in the areas of highest 
drug misuse and is of the opinion that they will 
continue to be a vital part of the local infrastructure 
for the foreseeable future. To date, LDTFs have 
implemented two rounds of actions plans, 
containing over 440 projects and are currently 
beginning an examination of emerging needs 
in their individual areas. They face a number of 
challenges going forward in relation to monitoring 
existing and new projects and fulfilling their key 
role of facilitating an effective response to the drug 
problems in their areas. The Steering Group believes 
that evaluation and mainstreaming21 of projects 
should continue to be a key feature of the operation 
of LDTFs. In this regard, the Steering Group notes 
that there are currently a number of obstacles 
to mainstreaming which need to be resolved, 
principally the financial and audit requirements on 
the State agencies through which funding for the 
projects is channelled.
7.4 The Steering Group considers that issues such 
as the level of commitment of members of LDTFs, 
participation of members and their understanding 
of their roles, as well as discontinuity caused by 
membership turnover, can impact on the effective 
operation of Task Forces. The Group believes that 
all partners should renew their commitment to the 
LDTFs, and provide enhanced training and support 
for their staff to engage fully in LDTF activities. In 
line with action 89, the NDST should continue to 
focus on strengthening and supporting community 
representation and participation on the Task Forces.
7.5 In relation to project monitoring by the LDTFs, 
the Steering Group notes that the forthcoming 
Goodbody Report22 puts greater stress on obtaining 
measurable outputs and outcomes from the LDTF 
projects, a process that would significantly add to 
the effectiveness of the LDTFs by assisting them in 
assessing their ongoing activities. The additional 
administrative supports for the LDTFs that will be 
rolled out during 2005 should facilitate this work by 
improving their operational capacity on the ground.
7.6 With regard to the YPFSF, the Steering Group 
notes the importance of continuing to develop 
and enhance the links between the Development 
Groups for the Fund and the LDTFs so as to 
maximise the level of integration and coherence 
on the ground. In this context, the Group notes 
that the role of the LDTF representative on the 
Development Group is to provide a continuing 
overview of the implementation and monitoring 
of the YPFSF plans and to provide for ongoing 
liaison and consultation so as to ensure that the 
views of the Task Force members are reflected on 
an ongoing basis. Ultimately, the Steering Group 
considers that programmes being funded through 
the Fund and the Task Forces should be linked 
and integrated to the fullest extent possible so as 
to ensure that the optimum benefit accrues to the 
young people and communities involved.
7.7 The Steering Group notes the evolving role of 
the RDTFs, including the completion of their first 
round of regional action plans. The Group is aware 
that during the consultation process, the resourcing 
21  A unique feature of the LDTF Initiative has been the “mainstreaming” of projects. In this instance, mainstreaming refers to the process 
whereby LDTF projects are evaluated and, if deemed to be working successfully, their funding is transferred to the relevant Department/
agency on an ongoing basis in accordance with agreed procedures.
22  Expenditure Review of the Local Drugs Task Forces carried out for the Department of Community, Rural & Gaeltacht Affairs by Goodbody 
Economic Consultants and due to be published in June 2005.
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and support for the RDTFs was highlighted as a 
cause of concern and believes that this presents a 
challenge for the remainder of the Strategy. In this 
regard, the absence of a full-time co-ordinator is 
seen as a key limitation to their development. The 
Group recommends that this and other staffing 
issues should be addressed at an early date. The 
Steering Group is strongly of the view that the issue 
of the appointment of full time co-ordinators, in 
particular, should be resolved as a matter of urgency 
and by June 2005 at the latest.
7.8 The Group believes that representatives of 
the statutory bodies who are members of LDTFs 
and RDTFs need to be mindful of their role. 
In particular, they should consult with – and 
bring relevant information to – their Task Forces 
regarding developments at both local and national 
levels within their organisations that impact on 
progressing actions in the NDS. They also need to 
ensure that their parent organisations are aware of 
developments within the Task Forces and how those 
developments impact on their agencies.
7.9 The Steering Group notes the appointment of 
an independent chairperson to the National Drugs 
Strategy Team (NDST) in 2004 and the increased 
capacity of the NDST arising out of the additional 
staff resources allocated as a result of the review in 
the NDS (action 83). These resources have allowed 
the NDST to fulfil more completely its terms of 
reference. The Group is aware that the NDST has a 
substantial workload over the remaining period of 
the Strategy, particularly in relation to the RDTFs, 
mainstreaming of LDTF projects, the Emerging 
Needs Fund for the LDTFs and the new Premises 
Initiative for Community Drugs Projects. In addition, 
the NDST has a continuing workload in relation to 
the existing projects from the two rounds of the 
LDTF plans and the Premises Initiative. These issues 
will continue to be the main focus of the work of 
the Team. The Group welcomes the development 
of a comprehensive database on the existing LDTF 
projects which should assist the NDST in their work, 
particularly in relation to monitoring outcomes 
and financial oversight. In this regard, the Steering 
Group believes that the operational capacity of 
the Team should be the subject of ongoing review 
to ensure its effectiveness and to foresee likely 
challenges.
7.10 The Group also feels that the NDST is in 
a unique position to identify service gaps and 
best practice approaches as well as trends and 
developments on the ground and to bring these 
issues to the attention of the IDG and the Minister 
of State. In addition, given the wide membership 
of the NDST, it can address routine co-ordination 
issues in relation to the work of the Task Forces and 
the implementation of the Strategy. In relation to 
the membership of the NDST, the Steering Group 
is cognisant of the need to reflect the interests of 
the RDTFs. In this regard, the Group believes that 
representation of the community and voluntary 
sector at NDST meetings should be augmented 
to include a member from each sector who could 
represent the views of the RDTFs at the Team. In 
addition, it is felt that Departmental and agency 
representatives should be able to discuss drugs 
services from a nationwide perspective. The Group 
also calls on the Department of Social & Family 
Affairs to renew its membership on the NDST. 
Furthermore, the Group is strongly of the view that 
future changes in Departmental or agency structure 
should not adversely impact on membership of the 
NDST or the Task Forces.
7.11 Accordingly, the Steering Group recommends 
that membership of the NDST should be made up 
as follows:
■ Department of Education & Science;
■ Department of Justice, Equality & Law Reform;
■ Department of Health & Children23;
■ Department of Community, Rural &  
Gaeltacht Affairs;
■ Department of the Taoiseach;
■ Department of Environment, Heritage  
& Local Government;
■ Department of Social & Family Affairs;
■ FÁS;
■ Garda Síochána;
■ Health Service Executive;
■ Community Sector – to represent LDTF  
and RDTF interests; and
■ Voluntary Sector – to represent LDTF  
and RDTF interests.
7.12 The Steering Group is of the opinion that 
the Inter-Departmental Group on Drugs (IDG) 
has not fulfilled the role envisaged in the NDS. 
Despite the fact that the IDG has been chaired by 
the Minister of State, Departments have not been 
represented as often as envisaged by Assistant 
Secretaries at these meetings. This is a capacity 
issue common to many co-ordinating structures. 
To date, all IDG meetings have effectively been 
joint IDG-NDST meetings, whereby statutory NDST 
members have often fulfilled two roles. Accordingly, 
the existence of an IDG as a separate body within 
the institutional structure is compromised. In this 
regard, the role of the IDG as set out in its terms of 
reference (action 82) i.e. an advisory body to the 
CCSI, has suffered. In order to strengthen this role, 
the Steering Group believes that the IDG should 
be re-constituted and its membership revised. This 
would strengthen the IDG as a decision-making 
body so that it can both anticipate and respond to 
implementation issues and/or new trends emerging 
that may affect the Strategy. In addition to this 
policy and overseeing role, it should resolve any 
23  In view of the health reforms, the Department of Health & Children believes that it will no longer have a role on the NDST.
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conflicts that arise over the direction of the Strategy 
and the roles of the key players. It needs, therefore, 
to re-establish a separate role within the NDS 
institutional structures, while retaining its linkages 
with the NDST.
7.13 Accordingly, the Steering Group recommends 
that membership of the IDG should comprise 
Assistant Secretaries or equivalent from the 
relevant Departments and agencies as well as the 
chairpersons of the NDST, the NACD and the NAC 
of the YPFSF. Departmental representatives should 
have the authority to make decisions on the issues 
being discussed. In addition, in order to preserve 
the engagement by the community and voluntary 
sector at this level, there should be a representative 
with a clear mandate from each of those sectors 
on the IDG. The Steering Group also believes that 
the re-constituted IDG will provide an opportunity 
for feedback and discussion on issues relating to 
drug misuse as they arise at EU and international 
fora. In order to fully maximise the time of the 
members, the Steering Group is of the opinion that 
meetings should be held at least once a quarter and 
in order to preserve the link with the NDST, joint 
meetings of the IDG and the NDST should occur 
every 6 months. The Group also feels that the HSE, 
the Prison Service and the Department of Social & 
Family Affairs should be represented on the IDG.
7.14 The role of the Drugs Strategy Unit in the 
Department of Community, Rural & Gaeltacht 
Affairs (D/CRGA) is not properly defined in 
the Strategy and the Group believes that this 
should be addressed in this review. One of the 
key functions of the Unit is to co-ordinate the 
overall implementation of the Strategy. In addition, 
the Unit carries out a range of other functions, 
including, advising and supporting the Minister of 
State, driving the implementation of the Strategy, 
monitoring and reporting on the implementation 
of the various NDS actions and highlighting gaps 
and issues arising to the IDG and the Cabinet 
Committee on Social Inclusion (CCSI). In addition, 
the Unit has responsibility for the operation and 
ongoing management of the YPFSF and it also 
chairs the British-Irish Council Sectoral Group on 
the Misuse of Drugs24. The Department also funds 
and is financially accountable for the work of the 
Task Forces, the YPFSF, the NACD and the NDST. In 
addition, the Unit represents Ireland at EU National 
Drugs Co-ordinators’ meetings which are usually 
held twice a year. The Minister of State is a member 
of the CCSI and ensures that the Committee is kept 
informed and aware of developments and issues 
around tackling drug misuse. In this context, the 
Steering Group notes the views expressed during 
the consultation process that consideration should 
be given to the appointment of a full-time Minister 
of State to the Drugs Strategy portfolio in light of 
the expanding range of initiatives under the NDS 
and the serious implications for society of the drugs 
issue.
7.15 The Steering Group is conscious of the 
concerns expressed throughout the consultation 
process about alcohol use and, in particular, binge 
drinking. Confusion was expressed during that 
process as to why alcohol and illegal drugs are 
dealt with by two separate strategies and many felt 
that they should be addressed through one overall 
policy. There are a number of strands to alcohol 
policy in Ireland. Among them are issues relating to:
■ prevention which is the responsibility of the 
health services and the education services;
■ treatment which is the responsibility of the 
health services; and
■ supply control related issues which are the 
responsibility of the Department of Justice, 
Equality & Law Reform and the Garda Síochána.
Overall co-ordination of alcohol policy is the 
responsibility of the Department of Health & 
Children. The question of a combined alcohol 
and drug strategy is, the Steering Group believes, 
beyond the remit of this review. However, in this 
regard, the Group would like to stress that although 
there are separate policies, in many cases, there are 
not separate services addressing issues of substance 
misuse on the ground.
7.16 Most educational activities in relation to 
prevention cover substance misuse in general 
rather than any specific substance or group of 
substances. However, awareness raising campaigns 
and campaign messages need to be focussed and 
credible. In this regard, the Steering Group is of the 
opinion that addressing alcohol and illicit drugs 
together is problematic, given that the messages 
communicated in relation to alcohol are not 
necessarily appropriate to illegal drugs. That said, 
there is still potential for some cross-over between 
campaigns. In relation to treatment for substance 
misuse, different clients have different needs, but 
treatment that is client-centred should address all 
the issues personal to that client including alcohol 
treatment, where necessary. The Steering Group 
notes that in the context of supply reduction, 
there are a number of issues that make closer 
linkages between policy on both alcohol and illicit 
drugs difficult to achieve. These relate principally 
to the different legal status of both substances. 
Notwithstanding these issues, the Steering Group is 
conscious of the links that exist between early use 
of alcohol and illicit drugs and believes that the laws 
regarding the sale and supply of alcohol should be 
24 The British-Irish Council (BIC) was created under Strand Three of the Good Friday Agreement in 1998 to promote positive, practical 
relationships among its Members which are the British and Irish Governments, the devolved administrations of N. Ireland, Wales, 
Scotland, Jersey, Guernsey and the Isle of Man. Since the first BIC Summit meeting in December 1999, the Irish Government has taken 
the lead in advancing work in relation to the issue of drug misuse.
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rigorously enforced. As regards structures dealing 
with both policies in the health services, including 
health promotion and addiction services, alcohol 
and illicit drugs are frequently addressed through 
linked structures. In this regard, the Steering Group 
notes that there are many areas of cross-over 
and synergy and these should be developed and 
formalised.
7.17 In regard to the actions in the NDS concerning 
the development of stronger linkages, (actions 80 
and 86) the Steering Group believes that cross-
representation and liaison, particularly between 
the NDST and the National Alcohol Advisor, 
should be strengthened and both the NDST and 
Department of Community, Rural & Gaeltacht 
Affairs should continue to be represented on any 
successor group to the Strategic Task Force on 
Alcohol (STFA)25. In addition, further examination 
of the linkages required at local and regional level 
is needed. Many of the Task Forces already deal 
with underage drinking as an illicit substance and, 
in most cases, prevention programmes operated 
through the Task Forces do not make any distinction 
between substances. However, in relation to the 
proposal made in the Report of the STFA (published 
in September 2004) that the Task Forces should 
oversee alcohol specific projects, the Steering Group 
would view this positively provided the capacity is 
available to do so and that funding for such projects 
is sourced from the appropriate bodies. LDTF 
oversight of alcohol projects should not be allowed 
to dilute funding allocated by the Department 
of Community, Rural & Gaeltacht Affairs for the 
provision of drugs services. Overall, it is the opinion 
of the Steering Group that the formation of closer 
synergies between the two policies at a strategic 
level has been impeded by the lack of comparable 
structures. That said, the Steering Group feels that 
opportunities for further linkages between the 
two policies should be pursued. Bearing in mind 
the developments in relation to alcohol policy 
arising out of the Report of the STFA, it is proposed 
that a working group – to be chaired by the 
Department of Health & Children – and involving 
key stakeholders of both the alcohol and drugs 
areas should be established to explore the potential 
for better co-ordination between the two areas and 
how synergies could be improved. The question of 
a combined strategy should also be looked at in this 
context. The Steering Group recommends that this 
working group should report by end 2006.
7.18 The Steering Group views the provision of 
family support services as crucial in delivering 
the strategic aim of reducing harm to families. The 
concept of family support is generally understood 
as the provision of services and interventions, both 
formal and informal, that support families. The 
range of services encompassed include, among 
other things:
■ parent education;
■ child development and education;
■ therapeutic interventions;
■ respite for families and drug misusers 
themselves;
■ home-based programmes;
■ youth work; and
■ community and personal development.
7.19 Research suggests that the support needs 
of families affected by drug use revolve around 
strengthening individual capacities, ensuring group 
and child-centred activities and responding to 
parents in need. It is clear from the recent NACD 
study published in 200426 that all family support 
services experience some degree of uncertainty 
in dealing with families with drug problems. 
This uncertainty arises from a lack of clarity in 
their role of providing a service to families with 
drug problems; lack of skills to work successfully 
with these families and lack of support within 
their organisations to deliver a service to these 
families. The Steering Group endorses the NACD 
recommendations emanating from their study, 
namely:
■ to increase the capacity of services to respond 
through an appropriate level of resources and 
training for staff in services;
■ to strengthen interagency links and networks by 
building knowledge of local community issues 
and attitudes thus improving communications; 
and
■ to develop relevant monitoring and evaluation 
tools to measure effectiveness of services.
7.20 The Steering Group acknowledges the 
considerable role that families play in drug 
prevention through caring for drug misusers 
and their children, as well as through successful 
drug treatment and social re-integration of those 
family members isolated by their drug problems. 
The Group is also conscious of the great harm 
experienced by families through drug misuse and 
notes the strong calls for family support services 
to feature much more prominently in the Strategy. 
Accordingly, the Steering Group believes that the 
provision of services for families of drug misusers 
should be prioritised, particularly in areas of highest 
need such as LDTFs. Many of the Task Forces have 
services in place already but gaps may need to be 
filled and the Group believes that the NDST should 
25  The STFA was established by the Minister for Health & Children in January 2002 to review international research so as to identify 
evidence-based measures effective in preventing alcohol related harm; to examine the changes in alcohol consumption and related 
harm in the last decade and to recommend specific, evidence based measures to Government to prevent and reduce alcohol related 
harm in Ireland. To date, the Task Force has published an interim report in May 2002 and a further report in September 2004.
26 The Role of Family Support Services in Drug Prevention published by the NACD in November, 2004.
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give guidance and direction to the LDTFs in this 
regard. The RDTFs should also provide mechanisms 
for the provision of family support services to 
those most in need in their areas. In addition, the 
potential role of non-drugs specific family support 
services in supporting the families of drug misusers 
has been noted in the 2004 NACD study and this 
should be further developed. Where these services 
exist, information should be made more widely 
available and more accessible to families who are 
seeking them.
7.21 The Steering Group is aware of the 
contribution that family support groups and their 
networks can and do make to the provision of 
information and support to families affected by 
drug misuse. The groups themselves provide peer 
support to family members and the networks 
facilitate these groups to develop at local, regional 
and national level, to share information, to identify 
common issues for these families and bring them 
to the attention at policy level through the NDS 
framework. The Steering Group believes that the 
work of family support groups and networks should 
continue to be encouraged and supported.
7.22 The Steering Group is aware that it has, 
to date, not proved possible to establish a sub-
committee on drugs (action 77) of the existing 
Oireachtas Committee on Arts, Sport, Tourism, 
Community, Rural & Gaeltacht Affairs, partly 
due to the wide range of responsibilities of that 
Committee. In order to progress this matter and 
recognising the workload of the Committee, the 
Group recommends that, rather than set up a 
specific sub-committee, the Minister of State meet 
with the full Committee to discuss the Strategy and 
its implementation twice a year.
KEY ISSUES EMERGING
7.23 The review has highlighted six key issues in 
relation to institutional structures which must be 
addressed over the remaining period of the Strategy. 
In the case of five of the issues, this can be done 
through replacing or amending existing actions. 
One new action is also required. The issues are as 
follows:
1.  ISSUE – Operation of the NDST – while 
additional staff have been allocated to the NDST 
thereby increasing its operational capacity, there 
is a need for a periodic review of the operation 
of the Team to ensure its ongoing effectiveness.
 Recommendation of the Steering Group:
■ The current arrangements in relation to the 
operation of the NDST should be formally 
reviewed after they have been in place for 
two years (Action 83 replaced).
 Department/Agency responsible: 
Department of Community, Rural & Gaeltacht 
Affairs/IDG
2. ISSUE -Membership of the NDST – with 
the establishment of the Regional Drugs 
Task Forces, there is a need to review the 
membership of the Team to ensure that 
the views of the RDTFs are represented. 
Representation by the Department of Social 
& Family Affairs on the Team should also be 
renewed.
 Recommendation of the Steering Group:
■ Community and voluntary sector 
representation on the NDST should be 
formally reviewed to ensure that both 
the LDTFs and RDTFs are adequately 
represented. The Department of Social & 
Family Affairs should also be represented on 
the Team (Action 83 replaced).
 Department/Agency responsible: IDG/NDST
3.  ISSUE – Role of the Inter-Departmental 
Group on Drugs – in order to strengthen the 
role of the IDG, it needs to be reconstituted and 
its membership revised.
 Recommendation of the Steering Group :
 ■ Membership of the IDG should consist of 
Assistant Secretaries or equivalent from the 
relevant Departments and Agencies as well as 
the chairpersons of the NDST, the NACD and 
the NAC for the YPFSF and representatives of 
the C&V sectors;
 ■ Departmental representatives should have the 
authority to make decisions on the relevant 
issues;
 ■ Meetings of the IDG should be held at least 
once a quarter and joint meetings with the 
NDST should be held every 6 months;
 ■ The HSE, the Irish Prison Service and the 
Department of Social & Family Affairs should be 
represented on the IDG. (Action 79 replaced).
 Department/Agency responsible: 
Department of Community, Rural & Gaeltacht 
Affairs
4. ISSUE – Alcohol – while alcohol and drug 
misuse are two separate policy areas there 
is a need to develop better linkages and 
co-ordination between them at policy and 
operational levels.
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 Recommendation of the Steering Group:
■ A working group involving key stakeholders 
of both the alcohol and drugs areas should 
be established to explore the potential for 
better co-ordination between the two areas 
and how synergies could be improved. 
The working group should also examine 
and make recommendations on whether a 
combined strategy is the appropriate way 
forward. It is recommended that the working 
group should report by end 2006 (Action 80 
amended).
 Department/Agency responsible: 
Department of Health & Children
5. ISSUE – Family support – families currently 
play a crucial role in assisting drug misusers to 
tackle their addictions and in caring for them 
and their children and this needs to be more 
explicitly recognised and supported.
 Recommendation of the Steering Group:
■ Family support services should be developed 
in line with the recommendations in the 
2004 NACD Report i.e.
● increasing the capacity of services to 
respond through an appropriate level 
of resources and training for staff in 
services;
● strengthening interagency links and 
networks by building knowledge of local 
community issues and attitudes thus 
improving communications; and
● developing relevant monitoring and 
evaluation tools to measure effectiveness 
of services.
■ The NDST should actively encourage the 
LDTFs and RDTFs to prioritise the provision 
of family support services in their areas and 
action plans.
■ Family support networks should be 
supported in their work in the areas of 
information provision and assistance to local 
family support groups. (New Action).
 Department/Agency responsible: National 
Drugs Strategy Team/Department of Social & 
Family Affairs/HSE
6. ISSUE – Oireachtas Committee – it has not 
proved possible to establish a sub-committee 
on drugs of the existing Oireachtas Committee 
on Arts, Sport, Tourism, Community, Rural & 
Gaeltacht Affairs, partly due to the wide range 
of responsibilities of that Committee.
 Recommendation of the Steering Group:
■ The Minister of State should meet with 
the Oireachtas Committee on Arts, Sport, 
Tourism, Community, Rural & Gaeltacht 
Affairs twice a year to discuss the NDS and 
its implementation (Action 77 replaced).
 Department/Agency responsible: Oireachtas 
Committee on Arts, Sport, Tourism, Community, 
Rural & Gaeltacht Affairs.
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PROGRESS ON ACTIONS UNDER THE CO-ORDINATION PILLAR
No. Agency Action Progress
1 D/CRGA The Department, through the IDG and the NDST to co-
ordinate the implementation of the National Drugs Strategy 
in partnership with Government Departments, State 
Agencies, and the community and voluntary sectors and 
to bring to the Cabinet Committee on Social Inclusion any 
identified issues which have a detrimental effect on the 
implementation of policy.
Completed/Ongoing 
Task
2 D/CRGA The IDG, in conjunction with the NDST, to establish an 
evaluation framework for the Strategy, incorporating the 
performance indicators against which progress under 
the four pillars will be assessed. Annual reports and mid-
term evaluations would facilitate progression towards 
key strategic goals. The cost effectiveness of the various 
elements of each pillar of the new Strategy should be 
established to enable priorities to be established and a re-
focussing if necessary, of strategic objectives from the mid-
term evaluation stage at 2004.
Completed/Ongoing 
Task
72 Professional 
Bodies and 
Training 
Institutes
To make drug prevention training available to individuals 
interacting with groups most at risk of drug misuse, such 
as youth workers, teachers, student welfare officers, GPs, 
pharmacists, nurses, counsellors, childcare workers, law 
enforcement agents, members of the judiciary etc.
Considerably more 
progress required
73 Public Media To encourage the media to play a larger role in creating a 
greater understanding of drug misuse throughout society. 
Informed coverage and analysis and debate of drugs issues 
on an ongoing basis within the public sphere will contribute 
to the successful implementation of the Strategy. In this 
regard, the role of the Department of Community, Rural & 
Gaeltacht Affairs, as the co-ordinator of the National Drugs 
Strategy, as a possible central source of information should 
be considered.
Completed/Ongoing 
Task
77 Oireachtas 
Committee 
on Drugs
To establish a dedicated drugs sub-committee of the 
existing departmental joint committee which would meet 
at least three times a year.
Considerably more 
progress required
78 IDG To be chaired by the Minister of State at the Department 
of Community, Rural & Gaeltacht Affairs. This will ensure 
greater co-ordination between the IDG constituents in the 
future and will help to maintain high-level representation 
and more effective communication between the IDG and 
the Cabinet Committee on Social Inclusion.
Completed/Ongoing 
Task
79 IDG Membership of IDG to be at Assistant Secretary level. 
Regular joint meetings between the IDG and the NDST to 
be held.
Completed/Ongoing 
Task
80 IDG, NDST & 
D/H&C
Develop formal links with National Alcohol Policy. Progress made/more 
work underway
81 IDG To seek reports from key service providers, on request, and 
to attend meetings, as appropriate. Representatives from 
voluntary, community and professional sectors to attend 
meetings, as appropriate.
Completed/Ongoing 
Task
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No. Agency Action Progress
82 IDG Terms of reference – advise Cabinet Committee on 
critical matters relating to the NDS, ensuring input of 
Departments/Agencies into operational difficulties, 
approving plans and initiatives of LDTFs and RDTFs, 
monitoring and evaluating their operation.
Completed/Ongoing 
Task
83 IDG (in 
conjunction- 
with the 
NDST)
Review membership of the Team immediately, and every 
two years subsequently. To review the workload of the 
NDST, in particular the need for a director to oversee the 
management of the Office and additional technical support 
workers.
Completed/Ongoing 
Task
84 IDG & NDST Departments and Agencies on the IDG and NDST to 
commit in writing to the process and the level and extent 
of representation should be specified.
Completed/Ongoing 
Task
85 NDST Implement the Terms of Reference of NDST. Completed/Ongoing 
Task
86 NDST To meet regularly with the Co-ordinator of the National 
Alcohol Policy and to be represented on the body  
co-ordinating National Alcohol Policy.
Progress made/more 
work underway
87 NDST Ensure representation on YPFSF bodies, nationally and 
locally.
Completed/Ongoing 
Task
88 NDST NDST to be updated on developments by Agencies. NDST 
work to be a core part of NDST members workload.
Completed/Ongoing 
Task
89 NDST To consider funding pilot training initiatives for RDTF/LDTF 
community representatives.
Completed/Ongoing 
Task
90 NDST Examine feasibility of standards and accreditation 
framework for Drug Workers.
Progress made/more 
work underway
91 NDST Disseminate models of best practice from work of LDTF/
RDTF.
Completed/Ongoing 
Task
92 NDST Establish RDTFs. Completed/Ongoing 
Task
93 RDTFs Representation on RDTF to be at senior level. Completed/Ongoing 
Task
94 RDTFs/ 
NDST
Membership of RDTFs. Completed/Ongoing 
Task
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CHAPTER 8 
OVERALL 
CONCLUSIONS 
OF THE STEERING 
GROUP
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8 Overall conclusions of 
the Steering Group
8.1 The National Drugs Strategy represents a 
critical cross-cutting area of public policy in Ireland 
involving a large number of statutory and non-
statutory agencies working in partnership. Following 
the review of the Strategy, the Steering Group has 
reached a number of key conclusions which are set 
out in this chapter. A number of other issues that 
arose in the context of the review are also examined 
below.
KEY FINDINGS
8.2 The key findings of the Steering Group are that 
the current aims and objectives of the Strategy 
are fundamentally sound and that progress is 
being made across the pillars of the Strategy, 
although it does vary from action to action. To 
date, the Strategy has focussed the activities of 
Departments and agencies on identified priorities 
so as to maximise the impact of their combined 
actions.
8.3 However, the Steering Group also found that 
some adjustments are required in order to re-
focus priorities and accelerate the roll-out and 
implementation of various key actions in the 
remaining period of the Strategy up to 2008. The 
implementation of the recommendations which are 
set out in Chapters 3-7 and outlined again below 
will serve to strengthen the overall shape of the 
Strategy and actively drive its implementation for 
the next three years.
8.4 The table below contains a summary of the 
state of play with the 100 actions in the NDS. 
Further details in relation to the actions is contained 
in the preceeding chapters.
PILLAR Total Number of 
Actions 
Completed/
Ongoing tasks
Progess made/
More work 
underway
Considerably 
more progress 
required
Supply Reduction 21 11 9 1
Prevention 16 11 5 –
Treatment 36 9 24 3
Research 5 1 4 –
Co-ordinating 
Structures
22 17 3 2
Total 100 49 45 6 
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RECOMMENDATIONS OF THE STEERING GROUP
8.5 The recommendations of the Steering Group are as follows:
PILLAR Recommendation Department/
Agency 
responsible
Existing 
action to be 
replaced or 
amended
New 
Action
SUPPLY 
REDUCTION
The level of Garda resources in LDTF areas 
should be increased and the additional 
resources should be assigned to community 
policing and the prevention of drug dealing.
Garda 
Síochána
Action 7 
replaced 
Taking into account the provisions of the 
Garda Síochána Bill 2004, Community 
Policing Fora should be extended to all 
LDTF areas and to other areas experiencing 
problems of drug misuse. 
Garda 
Síochána
Action 11 
replaced  
A framework of co-operation with the 
Judicial Studies Institute on the provision 
of specialist training on drug-related issues 
to members of the Judiciary should be 
developed by January 2007.
Courts Service  Yes 
PREVENTION, 
EDUCATION 
AND AWARENESS 
Substance use policies should be developed 
and implemented in all LDTF area schools 
by the end of the 2005/06 academic year.
D/E&S Action 43 
replaced 
A mechanism to monitor the development 
of substance use policies in all schools 
should be put in place and should report 
annually. 
D/E&S Action 43 
replaced
Appropriate and ongoing training and 
support services should be put in place on a 
nationwide basis for teachers to deliver the 
SPHE.
D/E&S 
HSE
Action 31 
amended 
The supports provided to LDTF area schools 
through the Walk Tall Support Service 
should be extended to other areas of 
disadvantage.
D/E&S 
HSE
Action 32 
amended 
Schools at primary and post-primary levels 
should further prioritise the implementation 
of SPHE and other school-based prevention 
programmes within existing timetables. 
D/E&S 
HSE
Action 33 
amended
Prevention education should be part of the 
curriculum for student teachers.
D/E&S Yes
A working group should be established 
– under the aegis of the Department 
of Education & Science – to examine 
the implementation of substance use 
programmes in non-school settings. The 
group should identify ongoing gaps and 
develop guidelines and models of best 
practice and it should report by January 
2006. 
D/E&S Action 37 
amended 
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PILLAR Recommendation Department/
Agency 
responsible
Existing 
action to be 
replaced or 
amended
New 
Action
Factual preventative information for parents 
and families in dealing with substance 
misuse should be more easily accessible 
in appropriate locations such as Garda 
Stations, health centres and other public 
offices.
D/E&S 
HSE 
Action 35 
replaced 
The role of the Home School Community 
Liaison Scheme should be further 
strengthened through the provision of 
additional resources. In particular, there is 
a need to expand the engagement of HSCL 
with families, particularly those dealing with 
drug misuse.
D/E&S Yes 
TREATMENT, 
REHABILITATION 
AND RISK 
REDUCTION
An audit of the current availability of 
treatment options should be carried out 
which should include an assessment of 
treatment needs and propose ways of 
tracking ongoing developments. The audit 
should be completed by mid 2006. 
HSE Yes 
In the context of increased poly-drug 
use, including cocaine and other drugs 
of dependence, increasing the availability 
and range of treatment options, including 
detoxification, should continue to be 
prioritised. This work should take on board 
the lessons of the pilot cocaine projects 
being rolled out in LDTF areas in 2005. 
HSE Action 48 
amended 
Rehabilitation should be the fifth pillar 
of the Strategy. In this context, a working 
group should be set up to develop an 
integrated rehabilitation provision. The 
group, to be chaired by the Department 
of Community, Rural & Gaeltacht Affairs 
should report to the IDG and the Cabinet 
Committee on Social Inclusion by the end 
of 2005 on the appropriate actions to be 
implemented. 
D/CRGA Yes 
The guidelines agreed by the Working 
Group on treatment for Under 18s should 
be fully implemented by end 2007, with 
priority given to areas of most need. 
HSE Action 49 
replaced 
The provision of needle exchange and 
related harm reduction services should 
be expanded in order to ensure wider 
geographic availability and availability at 
evenings and weekends, concentrating at 
first on areas of highest need. 
HSE Action 62 
replaced 
Appropriate treatment should be provided 
to problem drug users no later than one 
month after assessment. This target should 
be met by the end of 2007. 
HSE Action 44 
amended 
M
id-term
 R
eview
 of the  N
ational D
rugs Strategy 2001-2008
65
PILLAR Recommendation Department/
Agency 
responsible
Existing 
action to be 
replaced or 
amended
New 
Action
The numbers of GPs (in particular Level II 
GPs) and pharmacists participating in the 
methadone protocol, particularly in the 
areas of most need, should continue to be 
increased.
HSE Action 56 
replaced 
The Methadone Implementation Committee 
should examine the issue of the voluntary 
and community services employing medical 
staff directly and they should report to the 
IDG by the end of 2005. 
D/H&C Action 56 
replaced 
RESEARCH Monitoring the implementation of the 
recommendations arising from the NACD 
reports should become part of the NDS 
progress reports to the Cabinet Committee 
on Social Inclusion. Reporting on the NACD 
recommendations should be done annually. 
D/CRGA Yes 
The Central Methadone Treatment List 
should be developed by the provision of 
further information regarding entry and re-
entry of clients and the length of time in 
treatment and this additional information 
should be made available on an annual basis. 
Waiting lists for treatment in the various 
regions should also be developed by the HSE. 
HSE/DTCB Yes 
CO-ORDINATING 
STRUCTURES
The current arrangements in relation to the 
operation of the NDST should be formally 
reviewed after they have been in place for 
two years.
NDST 
D/CRGA
Action 83 
replaced 
Community and voluntary sector 
representation on the NDST should be 
formally reviewed to ensure that both 
the LDTFs and RDTFs are adequately 
represented. The Department of Social & 
Family Affairs should also be represented on 
the Team.
NDST Action 83 
replaced 
Membership of the IDG should consist of 
Assistant Secretaries or equivalent from 
the relevant Departments and agencies as 
well as the chairpersons of the NDST, the 
NACD and the NAC for the YPFSF and 
representatives from the C&V sectors.
Departmental representatives should have 
the authority to make decisions on the 
relevant issues being discussed.
Meetings of the IDG should be held at least 
once a quarter and joint meetings with the 
NDST should be held every 6 months.
The HSE, the Irish Prison Service and the 
Department of Social & Family Affairs 
should be represented on the IDG.
D/CRGA Action 79 
replaced 
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PILLAR Recommendation Department/
Agency 
responsible
Existing 
action to be 
replaced or 
amended
New 
Action
The Minister of State should meet with 
the Oireachtas Committee on Arts, Sport, 
Tourism, Community, Rural & Gaeltacht 
Affairs twice a year to discuss the NDS and 
its implementation.
D/CRGA Action 77 
replaced 
A working group involving key stakeholders 
of both the alcohol and drugs areas should 
be established to explore the potential for 
better co-ordination between the two areas 
and how synergies could be improved. 
The group should also examine and make 
recommendations on whether a combined 
strategy is the appropriate way forward. It 
is recommended that the working group 
should report by end 2006.
D/H&C Action 80 
amended 
CROSS-PILLAR Family support D/H&C  
D/SFA 
Yes 
The recommendations in the 2004 NACD 
Report (Role of Family Support Services in 
Drug Prevention) should be implemented, 
namely:
■ increasing the capacity of services to 
respond through an appropriate level 
of resources and training for staff in 
services;
■ strengthening interagency links and 
networks by building knowledge of local 
community issues and attitudes thus 
improving communications; and
■ developing relevant monitoring 
and evaluation tools to measure 
effectiveness of services.
The NDST should actively encourage the 
LDTFs and RDTFs to prioritise the provision 
of family support services in their areas and 
action plans.
Family support networks should be 
supported in their work in the areas of 
information provision and assistance to local 
family support groups.
 
 
 
 
 
 
 
 
 
 
 
 
 
NDST  
 
 
D/H&C  
D/SFA 
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8.6 In overall terms, the Steering Group’s 
recommendations will result in:
■ Ten of the Strategy’s existing actions being 
replaced;
■ A further seven of the existing actions being 
amended; and
■ Eight new actions.
In addition, a number of new key performance 
indicators are proposed under each of the pillars 
which are set out at the end of the relevant 
chapters.
FRAMEWORK FOR IMPLEMENTATION  
OF RECOMMENDATIONS
8.7 In conjunction with the relevant Departments 
and agencies, the Drugs Strategy Unit will draw 
up a revised framework for the implementation of 
the Steering Group’s recommendations, including 
timescales etc. This will be presented to the IDG 
within 3 months of the publication of this report.
RESOURCES FOR IMPLEMENTING THE 
RECOMMENDATIONS
8.8 In drawing up their recommendations the 
Steering Group is conscious and mindful of overall 
budgetary constraints to which Departments and 
agencies operate on an ongoing basis. Individual 
Departments will seek funding through the annual 
Estimates process over the next three years to 
implement the various recommendations, many 
of which will demand a re-focussing of existing 
resources – rather than additional resources – in 
order to accelerate the implementation of the 
actions.
8.9 However, the Group feels it is very important 
to point out that some of the recommendations, 
due to the need for extra services and staffing 
to implement them, carry significant additional 
resource implications if they are to be implemented 
over the remainder of the Strategy. These include:
■ Taking into account the provisions of the Garda 
Síochána Bill 2004, Community Policing Fora 
(CPF) should be extended to all LDTF areas and 
to other areas experiencing problems of drug 
misuse. (Garda Síochána)
■ To provide appropriate treatment to the 
drug misuser no later than one month after 
assessment. (HSE)
■ In the context of increased polydrug use, 
including cocaine and other drugs of 
dependence, to prioritise and continue to 
develop actions related to increasing the 
availability and range of treatment options. This 
should take on board the lessons of the pilot 
cocaine projects developed by the NDST. (HSE)
■ To expand provision of needle exchange and 
related harm reduction services in order to 
ensure wider geographic availability and at 
evenings and weekends, concentrating at first 
on areas of the highest need. (HSE)
COST EFFECTIVENESS OF THE VARIOUS 
ELEMENTS OF THE NDS
8.10 In the terms of reference for the review, the 
Steering Group was asked to look at the cost 
effectiveness of the various elements of the 
Strategy. To do this, it is necessary to look firstly 
at the resources allocated to addressing the 
drugs issue by Government. The Steering Group 
found that it is very difficult to quantify and 
measure these resources as they are spread across 
a number of different Departments, agencies, local 
authorities and other statutory bodies. Even within 
Departments and agencies, it can be difficult to 
accurately estimate spending associated with drug 
misuse as services such as An Garda Síochána, the 
Prisons, the Courts and Probation and Welfare and 
the various health and education services deal with 
drugs issues as part of their wider daily services.
8.11 However, the Group feels that such a measure 
of the expenditure is vital to gauge the cost 
effectiveness of the different elements of the 
Strategy. In this regard, the Group proposes that 
bearing in mind the complexities attached to this 
issue, only expenditure that is directly attributable 
to drugs programmes (e.g. drugs services of the 
Health Services, cost of Garda drug units, drugs 
specific training of prison officers etc.) should 
be measured. Although this would not capture 
the overall resources devoted to addressing the 
direct and indirect costs of drug use, it would give 
an indication as to the overall budget priorities 
accorded to this issue. Without such a measure, as 
imperfect as it may be, it is difficult to quantify the 
resources being committed to implementing the 
NDS. The Steering Group recommends that the 
Inter-Departmental Group on Drugs should consider 
how best this issue should be progressed and that 
the estimates should be produced on an annual 
basis.
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EU DRUGS ACTION PLAN
8.12 The Steering Group is also conscious that 
negotiations are ongoing at the time of writing on 
the EU Drugs Action Plan 2005-08. These actions 
will flow from the EU Drugs Strategy 2005-2012, 
which was agreed in December 2004 by the 
European Council. The multi-disciplinary, balanced 
approach of the National Drugs Strategy 2001-2008 
is consistent with the EU Strategy and the proposed 
actions of the new EU Drugs Action Plan are 
broadly consistent with those in the current Strategy 
and in this mid-term review. Accordingly, the Group 
is confident that the complementarities between 
national and EU approaches will be maintained.
OVERALL IMPACT OF THE STRATEGY
8.13 The review sought to assess the impact 
and direction of the Strategy at this mid-point 
stage and overall impacts cannot be measured 
until the Strategy as a whole is completed. In 
the circumstances, the Group concentrated on 
identifying adjustments to the existing Strategy. 
Accordingly, the review identified areas of progress 
in implementing the Strategy and highlighted 
priorities for the second phase up to 2008. By 
implementing the recommendations outlined in this 
report, the Steering Group believe that the Strategy 
can better deliver the aims and objectives set out 
for the period 2001-2008.
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Appendix 1
MID-TERM REVIEW OF THE NATIONAL DRUGS STRATEGY – STEERING GROUP 
Name Organisation
Ms. Kathleen Stack (chair) Department of Community, Rural & Gaeltacht Affairs
Ms. Alice O’Flynn Health Service Executive
Ms. Catherine Byrne Department of Justice, Equality & Law Reform 
Supt. Barry O’Brien An Garda Síochána  
Mr. David Moloney Department of Health & Children
Mr. Fergus McCabe CityWide – Community Sector
Ms. Mairéad Lyons National Advisory Committee on Drugs
Ms. Patricia O’Connor National Drugs Strategy Team
Mr. Andrew Diggins Department of Education & Science
Mr. Tony Geoghegan Merchants Quay Ireland – Voluntary Sector
Mr. David Gilbride Irish Prison Service
Secretariat
Úna Ní Fhaircheallaigh (secretary) Department of Community, Rural & Gaeltacht Affairs
Mr. John Kelly Department of Community, Rural & Gaeltacht Affairs
Ms. Sinéad Copeland Department of Community, Rural & Gaeltacht Affairs
Mr. Pat O’Grady Department of Community, Rural & Gaeltacht Affairs
Mr. Evan Breen Department of Community, Rural & Gaeltacht Affairs
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Individuals
Cllr. Mary Murphy
Cllr. Michael Conaghan, Lord Mayor of Dublin
Mr. David Graham
Dr. Bobby Smith
Fr. Peter McVerry
Mr. Ian McCabe
Mr. Julian Pugh
Mr. Mike Brennan
Mr. Paul Delaney
Ms. Ancilla O’Reilly
Ms. Maeve Shanley
Dr. Mary-Ellen McCann
Mr. Trevor Sargent T.D.
Mr. Stephen Harding
Mr. Michael Hickey
Ms. Helen Callan
Ms. Marina O’Brien
Mr. Brian O’Connor 
Organisations
Addiction Response Crumlin
Addiction Service ECAHB
Association of Garda Sergeants and Inspectors
Association of Secondary Teachers in Ireland
Balbriggan Awareness of Drugs
Ballybeg Action Group
Ballyfermot Advance Project
Ballyfermot Local Drugs Task Force
Ballyfermot STAR
Ballymun Local Drugs Task Force
Belong to Youth Project
Blanchardstown Local Drugs Task Force
Border Regional Authority
CARP – Killinarden Tallaght
Carrick-on-Suir Youth Information Centre
Casadh
Catholic Youth Care
Citywide Drugs Crisis Campaign
Citywide/Family Support Network
Clonmel Community Drugs Initiative
Clonmel Family Support Group
Community Addiction Team –  
Dún Laoghaire/Rathdown
Community Awareness of Drugs (CAD)
Consultant Psychiatrist in Addiction (NAHB/
Mountjoy Prison)
Coolamber Drug Rehabilitation Centre
Coolmine Therapeutic Community
Council for Addiction Information & Mediation 
(COAIM)
County Waterford Community Drugs Initiative
Courts Service
Department of Education & Science
Department of Foreign Affairs
Department of Health & Children
Department of Justice, Equality & Law Reform
DePaul Trust
Drogheda Partnership
Drogheda RAPID
Drug Awareness Programme (Crosscare) –  
Clonliffe College
Drug Education Workers Forum
Drug Misuse Research Division (DMRD) –  
Health Research Board
Dublin 12 Local Drugs Task Force
Dublin AIDS Alliance
Dublin City Council
Dublin City Development Board & Community 
Forum
Dublin North East Local Drugs Task Force
Dublin Regional Authority
Dún Laoghaire/Rathdown Community  
Addiction Team
Dún Laoghaire/Rathdown Local Drugs Task Force
Dun Laoghaire/Rathdown Outreach Project 
(D.R.O.P)
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East Coast Area Health Board
East Coast Regional Drugs Task Force
Eastern Regional Health Authority
European Cities Against Drugs (ECAD)
FÁS
Finglas/Cabra Local Drugs Task Force
Foróige
Forum for Young People in Galway City
Garda National Drugs Unit
Irish Association of Alcohol and Addiction 
Counsellors
Irish Bishop’s Drug Initiative
Irish Penal Reform Trust
Irish Pharmaceutical Union
Irish Prison Service
Irish Society for the Prevention of  
Cruelty to Children
Kerry Diocesan Youth Service
Kilbarrack Coast Community Programme
Labour Party
Laois County Development Board
Limerick City Development Board
Limerick City Drugs Prevention Group
Local Drugs Task Force Co-ordinators Network
Local Drugs Task Forces Community Representatives
Longford Traveller Movement
Merchants Quay Ireland
Mid-West Regional Drugs Task Force
Mid Western Health Board
National Advisory Committee on Drugs
National Council for Curriculum Assessment
National Drugs Strategy Team
North Eastern Health Board
North Eastern Regional Drugs Task Force
Northern Area Health Board, ERHA
North West Inner City Network (Dublin)
North Western Health Board
Ossary Youth
Pavee Point
Pharmaceutical Society of Ireland
Probation and Welfare Service
Regional Drugs Task Force Co-ordinators
Regional Drugs Task Force Community 
Representatives
Revenue Commissioners
Rialto Community Network Ltd.
School Completion Programme
SHY Project
Sinn Féin
Snug Counselling & Information Centre
South Eastern Health Board
Southern Regional Drugs Task Force
South Inner City Local Drugs Task Force (Dublin)
Southside Community Drugs Initiative
South Western Area Health Board, ERHA
Star Project Ballymun Ltd.
Step by Step
Substance Misuse Prevention Programme  
(Walk Tall)
Suir Valley Community Drugs Team
Talbot Centre
Tallaght Local Drugs Task Force
Tallaght Partnership
The Cornmarket Project
The Council for Addiction Information & Mediation
The Green Party
The Marian Centre, Bluebell
The Plough Youth Club
The Workers Party
Travellers Action (Trav Act)
TRUST
Voluntary Drug Treatment Network 
Waterford Community Based Drugs Initiative
Wexford Area Partnership
Wexford County Board Development Initiative
Working Group for Families Living in  
Emergency Accommodation
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Appendix 3
MID-TERM REVIEW – ORAL PRESENTATIONS TO THE STEERING GROUP 
An Garda Síochána
Association of Garda Sergeants and Inspectors
Citywide Drugs Crisis Campaign
Citywide Family Support Network
Department of Education & Science
Department of Environment, Heritage & Local Government
Department of Health & Children
Department of Justice, Equality & Law Reform
Drug Treatment Centre Board
Drug Users Fora/Groups
Eastern Regional Health Authority
FÁS
Irish College of General Practitioners
Irish Pharmaceutical Union
Irish Prison Service
Local Drugs Task Forces Community Representatives
Local Drugs Task Forces Co-ordinators
Local Drugs Task Forces Chairpersons
National Advisory Committee on Drugs
National Drugs Strategy Team
National Youth Council of Ireland
Probation and Welfare Service
Regional Drugs Task Forces Community Representatives
Regional Drugs Task Forces Co-ordinators
Revenue Commissioners – Customs and Excise Division
Voluntary Drug Treatment Network
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Cabinet Committee on Social Inclusion (CCSI)
The Cabinet Committee on Social Inclusion provides 
a strategic focus on tackling the problems of social 
inclusion, disadvantage and alienation. Its agenda, 
therefore, ranges across the responsibilities of a 
number of Ministers. The work of the Committee 
is guided by the provisions of Programmes for 
Government, social partnership agreements and the 
National Development Plan. It has a specific remit 
in relation to the National Anti Poverty Strategy and 
the National Drugs Strategy.
Inter Departmental Group (IDG)
■ To advise the CCSI on critical matters of a public 
policy nature relating to the National Drugs 
Strategy (NDS);
■ To ensure the timely and effective input of 
relevant Departments and agencies into any 
emerging operational difficulties or conflicts in 
relation to implementation of national drugs 
policy; and
■ To approve the plans and initiatives of the 
LDTFs and the proposed RDTFs and to 
monitor and evaluate the outcomes of their 
implementation through joint meetings with  
the NDST.
National Drugs Strategy Team (NDST)
■ To ensure effective co-ordination between 
officials from Government Departments and 
State Agencies represented on the Team and 
members of the community and voluntary 
sectors in delivering local and regional task force 
plans;
■ To review on an ongoing basis the need for 
LDTFs in disadvantaged urban areas, particularly 
having regard to evidence of localised heroin 
misuse;
■ To identify and consider policy issues and 
ensure that policy is informed by the work of 
and lessons from the LDTFs and the RDTFs, 
through joint meetings with the IDG;
■ To oversee the establishment of RDTFs;
■ To draw up guidelines for the operation of Local 
and Regional Drugs Task Forces and oversee 
their work;
■ To evaluate the Local and Regional Drugs Task 
Forces action plans and make recommendations 
to the IDG regarding the allocation of funding to 
support their implementation;
■ To ensure that monies allocated by the 
Department of Community, Rural & Gaeltacht 
Affairs to projects overseen by the NDST are 
properly accounted for; and
■ To prepare an annual report and present it 
to the Department of Community, Rural & 
Gaeltacht Affairs.
National Advisory Committee on Drugs (NACD)
On its establishment, the functions of NACD were 
set out as follows:
■ based on the Committee’s analysis and 
interpretation of research findings and 
information available to it, to advise the CCSI 
and through it, the Government, in relation 
to the prevalence, prevention, treatment and 
consequences of problem drug use in Ireland;
■ to review current information sets and 
research capacity in relation to the prevalence, 
prevention, treatment and consequences 
of problem drug use in Ireland and to make 
recommendations, as appropriate, on how 
deficits should be addressed including how to 
maximise the use of information available from 
the community and voluntary sector;
■ to oversee the delivery of a three year 
prioritised programme of research and 
evaluation as recommended by the Interim 
Advisory Committee to meet the gaps and 
priority needs identified by:
(a) using the capacity of relevant agencies 
engaged in information gathering and 
research, both statutory and non-statutory, 
to deliver on elements of the programme;
(b) liaising with these agencies with a view 
to maximising the resources allocated to 
delivering the programme and avoiding 
duplication;
(c) co-ordinating and advising on research 
projects in the light of the prioritised 
programme;
(d) commissioning research projects which 
cannot be met through existing capacity;
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■ to commission additional research at the request 
of the Government into drug issues of relevance 
to policy;
■ to work closely with the Health Research Board 
(HRB) on the establishment of a national 
information/research database (in relation 
to the prevalence, prevention, treatment and 
consequences of problem drug use) which is 
easily accessible; and
■ to advise relevant agencies with a remit to 
promote greater public awareness of the issues 
arising in relation to problem drug use and to 
promote and encourage debate through the 
dissemination of its research findings.
In addition, as part of their extended mandate, the 
Government identified (i) drugs and crime and (ii) 
rehabilitation as priority areas of research for the 
NACD for the period up to 2008.
National Assessment Committee (NAC) for  
the Young Peoples Facilities and Services  
Fund (YPFSF)
■ To prepare guidelines for the development of 
integrated plans in the target areas, which meet 
the overall aims of the Fund;
■ To assess the plans emanating from each of the 
target areas and to make recommendations on 
funding to the CCSI;
■ To monitor ongoing progress in the 
implementation of the local plans and address 
difficulties/issues arising; and
■ To identify and consider policy issues relevant to 
the operation of the Fund for consideration by 
the IDG.
Drugs Strategy Unit – Department of 
Community, Rural and Gaeltacht Affairs  
(D/CRGA)
■ To co-ordinate the overall implementation of the 
NDS;
■ To advise and support the Minister of State with 
responsibility for the NDS;
■ To drive the implementation of the NDS 
– particularly through the IDG;
■ To monitor and report on the implementation of 
the various NDS actions and highlight gaps and 
issues arising to the IDG and the CCSI;
■ To operate and manage the YPFSF and deal 
with emerging operational and policy issues in 
conjunction with the NAC;
■ To be financially accountable for the work of the 
LDTFs, the YPFSF, the NACD and the NDST;
■ To chair the British-Irish Council Sectoral Group 
on the Misuse of Drugs; and
■ To represent Ireland at EU National Drugs  
Co-ordinators meetings.
In addition, the Unit is represented on the NDST 
and the NACD as well as a number of other 
relevant Committees.
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Glossary of Terms
British-Irish Council – BIC
Cabinet Committee on Social Inclusion –  CCSI
Central Methadone Treatment List – CMTL
Central Statistics Office – CSO
Community and Voluntary – C&V
Community Employment  – CE
Community Policing Fora – CPF
County Development Boards – CDBs
Criminal Assets Bureau – CAB
Criminal Case Tracking System – CCTS
Customs & Excise – C&E
Department of Community, Rural & Gaeltacht Affairs – D/CRGA
Department of Education & Science – D/E&S
Department of Environment, Heritage and Local Government – D/EHLG
Department of Health & Children – D/H&C
Department of Justice, Equality & Law Reform – D/JELR
Department of Social & Family Affairs – D/SFA
Drug & Alcohol Information Research Unit (Northern Ireland) – DAIRU
Drug Misuse Research Division – DMRD
Drugs Strategy Unit – DSU
Eastern Regional Health Authority – ERHA
European Monitoring Centre for Drugs & Drug Addiction – EMCDDA
General Practitioner –  GP
Home School Community Liaison Scheme – HSCL
Health Board – HB
Health Research Board – HRB
Health Service Executive –  HSE
Inter-Departmental Group on Drugs – IDG
Integrated Services Process – ISP
Irish Hotel Federation – IHF
Irish Prison Service – IPS
Joint Policing Committees – JPC
Key Performance Indicator – KPI
Licensed Vintners Association – LVA
Local Authorities – LAs
Local Drugs Task Forces – LDTFs
National Advisory Committee on Drugs – NACD
National Assessment Committee of the YPFSF – NAC
National Children’s Office – NCO
National Development Plan – NDP
National Drugs Strategy Team – NDST
National Drug Treatment Reporting System – NDTRS
National Drugs Strategy 2001-2008 – NDS
National Educational Welfare Board – NEWB
Police Using Leading Systems Effectively – PULSE
Programme for Prosperity & Fairness – PPF
Regional Drugs Task Forces – RDTFs
School Completion Programme – SCP
Social Personal Health Education –  SPHE
Strategic Task Force on Alcohol – STFA
Vintners Federation of Ireland – VFI
Vocational Education Committee – VEC
Young People’s Facilities and Services Fund – YPFSF
